Exhibit 10.1


 


EXECUTION VERSION


 


COMMON STOCK PURCHASE AGREEMENT


 





Dated as of July 2, 2021


 


by and among


 


ASHFORD HOSPITALITY TRUST, INC.,


 


ASHFORD HOSPITALITY LIMITED PARTNERSHIP


 


and


 


B. RILEY PRINCIPAL CAPITAL, LLC


 






    


     


    

 


Table
of Contents


 


	 	 	 	 	Page
	 	 	 	 	 
	Article I
    DEFINITIONS	 	1
	 	 	 
	Article II
    PURCHASE AND SALE OF COMMON STOCK	 	1
	Section 2.1.	 	Purchase and Sale of Stock	 	1
	Section 2.2.	 	Closing Date; Settlements	 	2
	Section 2.3.	 	Initial Public Announcements and Required Filings	 	2
	 	 	 	 	 
	Article III
    PURCHASE TERMS	 	3
	Section 3.1.	 	VWAP Purchases	 	3
	Section 3.2.	 	Settlement	 	4
	Section 3.3.	 	Compliance with Rules of Trading Market.	 	4
	Section 3.4.	 	Beneficial Ownership Limitation	 	5
	 	 	 	 	 
	Article IV
    REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE
    INVESTOR	 	5
	Section 4.1.	 	Organization and Standing of the Investor	 	5
	Section 4.2.	 	Authorization and Power	 	5
	Section 4.3.	 	No Conflicts	 	6
	Section 4.4.	 	Investment Purpose	 	6
	Section 4.5.	 	Accredited Investor Status	 	6
	Section 4.6.	 	Reliance on Exemptions	 	7
	Section 4.7.	 	Information	 	7
	Section 4.8.	 	No Governmental Review	 	7
	Section 4.9.	 	No General Solicitation	 	7
	Section 4.10.	 	Not an Affiliate	 	7
	Section 4.11.	 	No Prior Short Sales	 	8
	Section 4.12.	 	Statutory Underwriter Status	 	8
	Section 4.13.	 	Resales of Securities	 	8
	 	 	 	 	 
	Article V
    REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE
    COMPANY AND THE OPERATING PARTNERSHIP	 	8
	Section 5.1.	 	Organization, Good Standing and Power	 	8
	Section 5.2.	 	Authorization, Enforcement	 	9
	Section 5.3.	 	Capitalization	 	10
	Section 5.4.	 	Issuance of Securities	 	10
	Section 5.5.	 	No Conflicts	 	10
	Section 5.6.	 	Commission Documents, Financial Statements; Disclosure
    Controls and Procedures; Internal Controls Over Financial Reporting; Accountants	 	11
	Section 5.7.	 	Due Authorization of Partnership Agreement	 	12
	Section 5.8.	 	Capitalization of Operating Partnership	 	12
	Section 5.9.	 	No Material Adverse Effect or Material Adverse Change	 	13
	Section 5.10.	 	Mortgages	 	13
	Section 5.11.	 	Solvency	 	13
	Section 5.12.	 	Property	 	14



 



    i


     


    




 


	Section 5.13.	 	Actions Pending	 	14
	Section 5.14.	 	Compliance With Laws	 	14
	Section 5.15.	 	Certain Fees	 	14
	Section 5.16.	 	Disclosure	 	15
	Section 5.17.	 	Regulatory Permits	 	15
	Section 5.18.	 	Environmental Compliance	 	16
	Section 5.19.	 	Material Agreements	 	17
	Section 5.20.	 	Transactions With Affiliates	 	17
	Section 5.21.	 	Intellectual Property Rights	 	17
	Section 5.22.	 	Use of Proceeds	 	18
	Section 5.23.	 	Investment Company Act Status	 	18
	Section 5.24.	 	Benefit Plans; Labor Matters	 	18
	Section 5.25.	 	Taxes	 	18
	Section 5.26.	 	Insurance	 	18
	Section 5.27.	 	Exemption from Registration	 	18
	Section 5.28.	 	No General Solicitation or Advertising	 	19
	Section 5.29.	 	No Integrated Offering	 	19
	Section 5.30.	 	Dilutive Effect	 	19
	Section 5.31.	 	Manipulation of Price	 	19
	Section 5.32.	 	Securities Act	 	19
	Section 5.33.	 	Listing and Maintenance Requirements; DTC Eligibility	 	20
	Section 5.34.	 	Application of Takeover Protections	 	20
	Section 5.35.	 	Foreign Corrupt Practices	 	20
	Section 5.36.	 	Money Laundering Laws	 	20
	Section 5.37.	 	OFAC	 	21
	Section 5.38.	 	Information Technology; Compliance With Data Privacy
    Laws	 	21
	Section 5.39.	 	No Disqualification Events	 	21
	Section 5.40.	 	REIT Status	 	21
	Section 5.41.	 	Authorization of Advisory Agreement	 	22
	Section 5.42.	 	No Other Similar Agreement	 	22
	Section 5.43.	 	Acknowledgement Regarding Investor’s Acquisition
    of Securities	 	22
	 	 	 
	Article VI
    ADDITIONAL COVENANTS	 	22
	Section 6.1.	 	Securities Compliance	 	22
	Section 6.2.	 	Reservation of Common Stock	 	22
	Section 6.3.	 	Registration and Listing	 	22
	Section 6.4.	 	Compliance with Laws.	 	23
	Section 6.5.	 	Keeping of Records and Books of Account; Due Diligence.	 	23
	Section 6.6.	 	No Frustration; No Dilutive Issuances During and Prior
    to Settlement of any VWAP Purchase.	 	24
	Section 6.7.	 	Corporate Existence	 	25
	Section 6.8.	 	Fundamental Transaction	 	25
	Section 6.9.	 	Selling Restrictions.	 	25
	Section 6.10.	 	Effective Registration Statement	 	26
	Section 6.11.	 	Blue Sky	 	26
	Section 6.12.	 	Non-Public Information	 	26
	Section 6.13.	 	Broker/Dealer	 	26



 






    ii


     


    

 


	Section 6.14.	 	Disclosure Schedule.	 	26
	Section 6.15.	 	Delivery of Bring Down Opinions and Compliance Certificates
    Upon Occurrence of Certain Events	 	27
	 	 	 	 	 
	Article VII
    CONDITIONS TO CLOSING AND CONDITIONS TO THE SALE
    AND PURCHASE OF THE SHARES	 	27
	Section 7.1.	 	Conditions Precedent to Closing	 	27
	Section 7.2.	 	Conditions Precedent to Commencement	 	28
	Section 7.3.	 	Conditions Precedent to VWAP Purchases after Commencement
    Date	 	31
	 	 	 	 	 
	Article VIII
    TERMINATION	 	35
	Section 8.1.	 	Automatic Termination	 	35
	Section 8.2.	 	Other Termination	 	35
	Section 8.3.	 	Effect of Termination	 	36
	 	 	 	 	 
	Article IX
    INDEMNIFICATION	 	36
	Section 9.1.	 	Indemnification of Investor	 	36
	Section 9.2.	 	Indemnification Procedures	 	37
	 	 	 	 	 
	Article X
    MISCELLANEOUS	 	38
	Section 10.1.	 	Certain Fees and Expenses; Commencement Irrevocable
    Transfer Agent Instructions.	 	38
	Section 10.2.	 	Specific Enforcement, Consent to Jurisdiction, Waiver
    of Jury Trial.	 	38
	Section 10.3.	 	Entire Agreement	 	39
	Section 10.4.	 	Notices	 	39
	Section 10.5.	 	Waivers	 	40
	Section 10.6.	 	Amendments	 	40
	Section 10.7.	 	Headings	 	40
	Section 10.8.	 	Construction	 	41
	Section 10.9.	 	Binding Effect	 	41
	Section 10.10.	 	No Third Party Beneficiaries	 	41
	Section 10.11.	 	Governing Law	 	41
	Section 10.12.	 	Survival	 	41
	Section 10.13.	 	Counterparts	 	41
	Section 10.14.	 	Publicity	 	42
	Section 10.15.	 	Severability	 	42
	Section 10.16.	 	Further Assurances	 	42
	 	 	 	 	 
	Annex
    I. Definitions	 	 


 






    iii


     


    

 


COMMON
STOCK PURCHASE AGREEMENT


 


This COMMON STOCK PURCHASE
AGREEMENT is made and entered into as of July 2, 2021 (this “Agreement”), by and among B. Riley Principal
Capital, LLC, a Delaware limited liability company (the “Investor”), Ashford Hospitality Trust, Inc.,
a Maryland corporation (the “Company”), and Ashford Hospitality Limited Partnership, a Delaware limited partnership
(the “Operating Partnership”).


 


RECiTALS


 


WHEREAS,
the parties desire that, upon the terms and subject to the conditions and limitations set forth herein, the Company may issue and sell
to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to 46,227,744 shares of the
Company’s Common Stock, par value $0.01 per share (“Common Stock”), subject to the Aggregate Limit;


 


WHEREAS,
such sales of Common Stock by the Company to the Investor will be made in reliance upon the provisions of Section 4(a)(2) of
the Securities Act (“Section 4(a)(2)”), and upon such other exemption from the registration requirements
of the Securities Act as may be available with respect to any or all of the sales of Common Stock to the Investor to be made hereunder;
and


 


WHEREAS,
the parties hereto are concurrently entering into a Registration Rights Agreement in the form attached as Exhibit A
hereto (the “Registration Rights Agreement”), pursuant to which the Company shall register the resale of
the Registrable Securities (as defined in the Registration Rights Agreement), upon the terms and subject to the conditions set forth
therein.


 


NOW,
THEREFORE, the parties hereto, intending to be legally bound, hereby agree as follows:


 


Article I

DEFINITIONS


 


Capitalized terms used in
this Agreement shall have the meanings ascribed to such terms in Annex I hereto, and hereby made a part hereof, or as otherwise
set forth in this Agreement.


 


Article II

PURCHASE AND SALE OF COMMON STOCK


 


Section 2.1.           Purchase
and Sale of Stock. Upon the terms and subject to the conditions of this Agreement, during the Investment
Period, the Company, in its sole discretion, shall have the right, but not the obligation, to issue and sell to the Investor, and the
Investor shall purchase from the Company, up to 46,227,744 duly authorized, validly issued, fully paid and non-assessable shares of Common
Stock (the “Total Purchase Commitment”), subject to the Aggregate Limit, by the delivery to the Investor of
VWAP Purchase Notices as provided in Article III.


 






    


     


    

 


Section 2.2.           Closing
Date; Settlements. This Agreement shall become effective and binding (the “Closing”)
upon (a) the payment of the Investor Expense Reimbursement to the Investor prior to the Closing pursuant to Sections 7.1 and 10.1(i),
(b) the delivery of counterpart signature pages of this Agreement and the Registration Rights Agreement executed by each of
the parties hereto and thereto, and (c) the delivery of all other documents, instruments and writings required to be delivered at
the Closing, in each case as provided in Section 7.1, to the offices of Dorsey & Whitney LLP, 51 West 52nd Street,
New York, NY 10019-6119, at 4:00 p.m., New York City time, on the Closing Date. In consideration of and in express reliance upon the
representations, warranties and covenants contained in, and upon the terms and subject to the conditions of, this Agreement, during the
Investment Period, the Company, at its sole option and discretion, may issue and sell to the Investor, and, if the Company elects to
so issue and sell, the Investor shall purchase from the Company, the Shares in respect of each VWAP Purchase. The delivery of Shares
in respect of each VWAP Purchase, and the payment for such Shares, shall occur in accordance with Section 3.2, provided that
all of the conditions precedent in Article VII shall have been fulfilled at the applicable times set forth in Article VII.


 


Section 2.3.           Initial
Public Announcements and Required Filings. The Company shall, within the time period required under
the Exchange Act, file with the Commission a Current Report on Form 8-K describing the material terms of the transactions contemplated
by the Transaction Documents and attaching as exhibits thereto copies of each of this Agreement, the Registration Rights Agreement and,
if applicable, any press release issued by the Company disclosing the execution of this Agreement by the Company and the Operating Partnership
(including all exhibits thereto, the “Current Report”). The Company shall provide the Investor a reasonable
opportunity to comment on a draft of the Current Report prior to filing the Current Report with the Commission and shall give due consideration
to all such comments. From and after the filing of the Current Report with the Commission, the Company and the Operating Partnership
shall have publicly disclosed all material, nonpublic information delivered to the Investor (or the Investor’s representatives
or agents) by the Company, any of its Subsidiaries or the Operating Partnership, or any of their respective officers, directors, employees,
agents or representatives (if any) in connection with the transactions contemplated by the Transaction Documents. The Investor covenants
that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company as described in this Section 2.3,
the Investor shall maintain the confidentiality of all disclosures made to it in connection with the transactions contemplated by the
Transaction Documents (including the existence and terms of the transactions), except that the Investor may disclose the terms of such
transactions to its financial, accounting, legal and other advisors (provided that the Investor directs such Persons to maintain the
confidentiality of such information). The Company shall use its commercially reasonable efforts to prepare and, as soon as practicable,
but in no event later than the applicable Filing Deadline, file with the Commission the Initial Registration Statement and any New Registration
Statement covering only the resale by the Investor of the Registrable Securities in accordance with the Securities Act and the Registration
Rights Agreement. At or before 8:30 a.m. (New York City time) on the Trading Day immediately following the Effective Date of the
Initial Registration Statement and any New Registration Statement (or any post-effective amendment thereto), the Company shall use its
commercially reasonable efforts to file with the Commission in accordance with Rule 424(b) under the Securities Act the final
Prospectus to be used in connection with sales pursuant to such Registration Statement (or post-effective amendment thereto).


 






    	 	2	 



     

    

 



 


Article III

PURCHASE TERMS


 


Subject to the satisfaction
of the conditions set forth in Article VII, the parties agree as follows:


 


Section 3.1.           VWAP
Purchases. Upon the initial satisfaction of all of the conditions set forth in set forth
in Section 7.2 (the “Commencement” and the date of initial satisfaction of all of such conditions, the
 “Commencement Date”) and from time to time thereafter, subject to the satisfaction of all of the conditions
set forth in Section 7.3, the Company shall have the right, but not the obligation, to direct the Investor, by its timely delivery
to the Investor of a VWAP Purchase Notice, after 6:00 a.m., New York City time, but prior to 9:00 a.m., New York City time, on a VWAP
Purchase Date, to purchase the applicable VWAP Purchase Share Amount, not to exceed the applicable VWAP Purchase Maximum Amount, at the
applicable VWAP Purchase Price therefor on the applicable VWAP Purchase Date in accordance with this Agreement in accordance with this
Agreement (each such purchase, a “VWAP Purchase”). The Company may timely deliver a VWAP Purchase Notice to
the Investor as often as every Trading Day, so long as (i) the Closing Sale Price of the Common Stock on the Trading Day immediately
preceding such Trading Day is not less than the Threshold Price, and (ii) all Shares subject to all prior VWAP Purchases theretofore
required to have been received by the Investor as DWAC Shares under this Agreement have been delivered to the Investor as DWAC Shares
in accordance with this Agreement. The Investor is obligated to accept each VWAP Purchase Notice prepared and delivered by the Company
in accordance with the terms of and subject to the satisfaction of the conditions contained in this Agreement. If the Company delivers
any VWAP Purchase Notice directing the Investor to purchase a VWAP Purchase Share Amount in excess of the applicable VWAP Purchase Maximum
Amount, such VWAP Purchase Notice shall be void ab initio to the extent of the amount by which the VWAP Purchase Share Amount
set forth in such VWAP Purchase Notice exceeds such applicable VWAP Purchase Maximum Amount, and the Investor shall have no obligation
to purchase such excess Shares in respect of such VWAP Purchase Notice; provided, however, that the Investor shall remain
obligated to purchase the applicable VWAP Purchase Maximum Amount in such VWAP Purchase. At or prior to 5:30 p.m., New York City time,
on the VWAP Purchase Date for each VWAP Purchase, the Investor shall provide to the Company a written confirmation for such VWAP Purchase
(each, a “VWAP Purchase Confirmation”) setting forth the applicable VWAP Purchase Price per Share to be paid
by the Investor in such VWAP Purchase, and the total aggregate VWAP Purchase Price to be paid by the Investor for the total VWAP Purchase
Share Amount purchased by the Investor in such VWAP Purchase. Notwithstanding the foregoing, the Company shall not deliver any VWAP Purchase
Notices to the Investor during the PEA Period.


 






    	 	3	 



     

    

 


Section 3.2.           Settlement.
The Shares constituting the applicable VWAP Purchase Share Amount purchased by the Investor in each VWAP Purchase shall be delivered
to the Investor as DWAC Shares not later than 1:00 p.m., New York City time, on the Trading Day immediately following the applicable
VWAP Purchase Date for such VWAP Purchase (the “VWAP Purchase Share Delivery Date”) (it being acknowledged
and agreed that the Company may not deliver any additional VWAP Purchase Notice to the Investor until all such Shares subject to such
VWAP Purchase, and all Shares subject to all prior VWAP Purchase Notices, have been received by the Investor as DWAC Shares in accordance
with this Agreement). For each VWAP Purchase, the Investor shall pay to the Company an amount in cash equal to the product of (a) the
total number of Shares purchased by the Investor in such VWAP Purchase and (b) the applicable VWAP Purchase Price for such Shares,
as full payment for such Shares purchased by the Investor in such VWAP Purchase, via wire transfer of immediately available funds, not
later than 5:00 p.m., New York City time, on the Trading Day immediately following the applicable VWAP Purchase Share Delivery Date for
such VWAP Purchase, provided the Investor shall have timely received, as DWAC Shares, all of such Shares purchased by the Investor in
such VWAP Purchase on such VWAP Purchase Share Delivery Date in accordance with the first sentence of this Section 3.2, or, if any
of such Shares are received by the Investor after 1:00 p.m., New York City time, then the Company’s receipt of such funds in its
designated account may occur on the Trading Day next following the Trading Day on which the Investor shall have received all of such
Shares as DWAC Shares, but not later than 5:00 p.m., New York City time, on such next Trading Day. If the Company or the Transfer Agent
shall fail for any reason to deliver to the Investor, as DWAC Shares, any Shares purchased by the Investor in a VWAP Purchase prior to
10:30 a.m., New York City time, on the Trading Day immediately following the applicable VWAP Purchase Share Delivery Date for such VWAP
Purchase, and if on or after such Trading Day the Investor purchases (in an open market transaction or otherwise) shares of Common Stock
to deliver in satisfaction of a sale by the Investor of such Shares that the Investor anticipated receiving from the Company on such
VWAP Purchase Share Delivery Date in respect of such VWAP Purchase, then the Company shall, within one (1) Trading Day after the
Investor’s request, either (i) pay cash to the Investor in an amount equal to the Investor’s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased (the “Cover Price”), at which point
the Company’s obligation to deliver such Shares as DWAC Shares shall terminate, or (ii) promptly honor its obligation to deliver
to the Investor such Shares as DWAC Shares and pay cash to the Investor in an amount equal to the excess (if any) of the Cover Price
over the total purchase price paid by the Investor pursuant to this Agreement for all of the Shares purchased by the Investor in such
VWAP Purchase. The Company shall not issue any fraction of a share of Common Stock to the Investor in connection with any VWAP Purchase
effected pursuant to this Agreement. If the issuance would result in the issuance of a fraction of a share of Common Stock, the Company
shall round such fraction of a share of Common Stock up or down to the nearest whole share. All payments to be made by the Investor pursuant
to this Agreement shall be made by wire transfer of immediately available funds to such account as the Company may from time to time
designate by written notice to the Investor in accordance with the provisions of this Agreement.


 


Section 3.3.          Compliance
with Rules of Trading Market.


 


(a)            Share
Issuance Restriction. The Company shall not issue or sell any shares of Common Stock pursuant to this Agreement, and the Investor
shall not purchase or acquire any shares of Common Stock pursuant to this Agreement, to the extent that after giving effect thereto,
the aggregate number of shares of Common Stock that would be issued pursuant to this Agreement and the transactions contemplated hereby
would exceed 46,227,744 (representing 19.99% of the shares of Common Stock issued and outstanding immediately prior to the execution
of this Agreement), which number of shares shall be reduced, on a share-for-share basis, by the number of shares of Common Stock issued
or issuable pursuant to any transaction or series of transactions that may be aggregated with the transactions contemplated by this Agreement
under applicable rules of the Trading Market (such maximum number of shares of Common Stock issuable by the Company under this Agreement,
the “Aggregate Limit”).


 






    	 	4	 



     

    

 


(b)           General.
The Company shall not issue or sell any shares of Common Stock pursuant to this Agreement if such issuance or sale would reasonably
be expected to result in (A) a violation of the Securities Act or (B) a breach of the rules of the Trading Market. The
provisions of this Section 3.3 shall be implemented in a manner otherwise than in strict conformity with the terms of this Section 3.3
only if necessary to ensure compliance with the Securities Act and the applicable rules of the Trading Market.


 


Section 3.4.           Beneficial
Ownership Limitation. Notwithstanding anything to the contrary contained in this Agreement,
the Company shall not issue or sell, and the Investor shall not purchase or acquire, any shares of Common Stock under this
Agreement which, when aggregated with all other shares of Common Stock then beneficially owned by the Investor and its affiliates
(as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the
beneficial ownership by the Investor of more than 4.99% of the outstanding shares of Common Stock (the “Beneficial
Ownership Limitation”). Upon the written or oral request of the Investor, the Company shall promptly (but not later than
the next business day on which the Transfer Agent is open for business) confirm orally or in writing to the Investor the number of shares
of Common Stock outstanding as of the most recent date for which the Transfer Agent has such information. The Investor and the Company
shall each cooperate in good faith in the determinations required under this Section 3.4 and the application of this Section 3.4.
The Investor’s written certification to the Company of the applicability of the Beneficial Ownership Limitation, and the resulting
effect thereof hereunder at any time, shall be conclusive with respect to the applicability thereof and such result absent manifest error.
The provisions of this Section 3.4 shall be construed and implemented in a manner otherwise than in strict conformity with the terms
of this Section 3.4 to the extent necessary to properly give effect to the limitations contained in this Section 3.4.


 


Article IV

REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE INVESTOR


 


The Investor hereby makes
the following representations, warranties and covenants to the Company and the Operating Partnership:


 


Section 4.1.           Organization
and Standing of the Investor. The Investor is a limited liability company duly organized,
validly existing and in good standing under the laws of the State of Delaware.


 


Section 4.2.           Authorization
and Power. The Investor has the requisite limited liability company power and authority
to enter into and perform its obligations under this Agreement and the Registration Rights Agreement and to purchase or acquire the Securities
in accordance with the terms hereof. The execution, delivery and performance by the Investor of this Agreement and the Registration Rights
Agreement and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary limited
liability company action, and no further consent or authorization of the Investor, its Board of Directors or its members is required.
Each of this Agreement and the Registration Rights Agreement has been duly executed and delivered by the Investor and constitutes a valid
and binding obligation of the Investor enforceable against it in accordance with its terms, except as such enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship, receivership, or similar laws relating
to, or affecting generally the enforcement of, creditor’s rights and remedies or by other equitable principles of general application
(including any limitation of equitable remedies).


 






    	 	5	 



     

    

 


Section 4.3.           No
Conflicts. The execution, delivery and performance by the Investor of this Agreement and
the Registration Rights Agreement and the consummation by the Investor of the transactions contemplated hereby and thereby do not and
shall not (i) result in a violation of such Investor’s certificate of formation, limited liability company agreement or other
applicable organizational instruments, (ii) conflict with, constitute a default (or an event which, with notice or lapse of time
or both, would become a default) under, or give rise to any rights of termination, amendment, acceleration or cancellation of, any material
agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Investor is
a party or is bound, (iii) create or impose any lien, charge or encumbrance on any property of the Investor under any agreement
or any commitment to which the Investor is party or under which the Investor is bound or under which any of its properties or assets
are bound, or (iv) result in a violation of any federal, state, local or foreign statute, rule, or regulation, or any order, judgment
or decree of any court or governmental agency applicable to the Investor or by which any of its properties or assets are bound or affected,
except, in the case of clauses (ii), (iii) and (iv), for such conflicts, defaults, terminations, amendments, acceleration, cancellations
and violations as would not, individually or in the aggregate, prohibit or otherwise interfere with, in any material respect, the ability
of the Investor to enter into and perform its obligations under this Agreement and the Registration Rights Agreement. The Investor is
not required under any applicable federal, state, local or foreign law, rule or regulation to obtain any consent, authorization
or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform
any of its obligations under this Agreement and the Registration Rights Agreement or to purchase or acquire the Securities in accordance
with the terms hereof; provided, however, that for purposes of the representation made in this sentence, the Investor is
assuming and relying upon the accuracy of the relevant representations and warranties and the compliance with the relevant covenants
and agreements of the Company and the Operating Partnership in the Transaction Documents to which it is a party.


 


Section 4.4.           Investment
Purpose. The Investor is acquiring the Securities for its own account, for investment purposes
and not with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered
under or exempt from the registration requirements of the Securities Act; provided, however, that by making the representations
herein, the Investor does not agree, or make any representation or warranty, to hold any of the Securities for any minimum or other specific
term and reserves the right to dispose of the Securities at any time in accordance with, or pursuant to, a registration statement filed
pursuant to the Registration Rights Agreement or an applicable exemption under the Securities Act. The Investor does not presently have
any agreement or understanding, directly or indirectly, with any Person to sell or distribute any of the Securities.


 


Section 4.5.           Accredited
Investor Status. The Investor is an “accredited investor” as that term is defined
in Rule 501(a) of Regulation D.


 






    	 	6	 



     

    

 


Section 4.6.           Reliance
on Exemptions. The Investor understands that the Securities are being offered and sold to
it in reliance on specific exemptions from the registration requirements of U.S. federal and state securities laws and that the Company
is relying upon the truth and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Investor set forth herein in order to determine the availability of such exemptions and the eligibility of
the Investor to acquire the Securities.


 


Section 4.7.           Information.
All materials relating to the business, financial condition, management and operations of the Company, the Operating Partnership
and materials relating to the offer and sale of the Securities which have been requested by the Investor have been furnished or otherwise
made available to the Investor or its advisors, including, without limitation, the Commission Documents. The Investor understands that
its investment in the Securities involves a high degree of risk. The Investor is able to bear the economic risk of an investment in the
Securities and has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks
of a proposed investment in the Securities. The Investor and its advisors have been afforded the opportunity to ask questions of and
receive answers from representatives of the Company and the Operating Partnership concerning the financial condition and business of
the Company and other matters relating to an investment in the Securities. Neither such inquiries nor any other due diligence investigations
conducted by the Investor or its advisors, if any, or its representatives shall modify, amend or affect the Investor’s right to
rely on the Company’s representations and warranties contained in this Agreement or in any other Transaction Document to which
the Company is a party or the Investor’s right to rely on any other document or instrument executed and/or delivered in connection
with this Agreement or the consummation of the transaction contemplated hereby (including, without limitation, the opinions of the Company’s
counsel delivered pursuant to Section 7.2(xvi)). The Investor has sought such accounting, legal and tax advice as it has considered
necessary to make an informed investment decision with respect to its acquisition of the Securities. The Investor understands that it
(and not the Company or the Operating Partnership) shall be responsible for its own tax liabilities that may arise as a result of this
investment or the transactions contemplated by this Agreement.


 


Section 4.8.           No
Governmental Review. The Investor understands that no United States federal or state agency
or any other government or governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness
or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the
Securities.


 


Section 4.9.           No
General Solicitation. The Investor is not purchasing or acquiring the Securities as a result
of any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale
of the Securities.


 


Section 4.10.         Not
an Affiliate. The Investor is not an officer, director or an Affiliate of the Company. As
of the date of this Agreement, the Investor does not beneficially own any shares of Common Stock or securities exercisable for or convertible
into shares of Common Stock, and during the Investment Period, the Investor will not acquire beneficial ownership of any shares of the
Company’s capital stock (including shares of Common Stock or securities exercisable for or convertible into shares of Common Stock)
other than pursuant to this Agreement; provided, however, that nothing in this Agreement shall prohibit or be deemed to
prohibit the Investor from purchasing, in an open market transaction or otherwise, shares of Common Stock necessary to make delivery
by the Investor in satisfaction of a sale by the Investor of Shares that the Investor anticipated receiving from the Company in connection
with the settlement of a VWAP Purchase if the Company or its transfer agent shall have failed for any reason (other than a failure of
the Investor or its Broker-Dealer to set up a DWAC and required instructions) to electronically transfer all of the Shares subject to
such VWAP Purchase to the Investor on the applicable VWAP Purchase Share Delivery Date by crediting the Investor’s or its designated
Broker-Dealer’s account at DTC through its DWAC delivery system in compliance with Section 3.2 of this Agreement.


 



    	 	7	 



     

    




 


Section 4.11.         No
Prior Short Sales. At no time prior to the date of this Agreement has any of the Investor,
its agents, representatives or Affiliates engaged in or effected, in any manner whatsoever, directly or indirectly, any (i) “short
sale” (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock or (ii) hedging
transaction, which establishes a net short position with respect to the Common Stock.


 


Section 4.12.         Statutory
Underwriter Status. The Investor acknowledges that it will be disclosed as an “underwriter”
and a “selling stockholder” in each Registration Statement and in any Prospectus contained therein to the extent required
by applicable law and to the extent the Prospectus is related to the resale of Registrable Securities.


 


Section 4.13.         Resales
of Securities. The Investor represents, warrants and covenants that it will resell such
Securities only pursuant to the Registration Statement in which the resale of such Securities is registered under the Securities Act,
in a manner described under the caption “Plan of Distribution” in such Registration Statement, and in a manner in compliance
with all applicable U.S. federal and state securities laws, rules and regulations.


 


Article V

REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY AND THE OPERATING PARTNERSHIP


 


Except as set forth in the
disclosure schedule delivered by the Company to the Investor (which is hereby incorporated by reference in, and constitutes an integral
part of, this Agreement) (the “Disclosure Schedule”), each of the Company and the Operating Partnership, jointly
and severally, hereby makes the following representations, warranties and covenants to the Investor:


 


Section 5.1.          Organization,
Good Standing and Power. The Company and each subsidiary of the Company, including the Operating
Partnership and its subsidiaries (each, a “Subsidiary” and collectively, the “Subsidiaries”),
is an entity duly incorporated or otherwise organized, validly existing corporation, limited partnership or limited liability company,
as applicable, and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite corporate
or other power and authority to own and use its properties and assets and to carry on its business as currently conducted.  Each
of the Company and its Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity
in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except
where the failure to be so qualified or in good standing, as the case may be, would not reasonably be expected to result in a Material
Adverse Effect, and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification. Except as disclosed in the Filed Commission Documents, no Subsidiary is prohibited
or restricted, directly or indirectly, from paying dividends to the Company, or from making any other distribution with respect to such
Subsidiary’s capital stock or other equity interests or from repaying to the Company or any other Subsidiary any amounts that may
from time to time become due under any loans or advances to such Subsidiary from the Company or such other Subsidiary, or from transferring
any such Subsidiary’s property or assets to the Company or to any other Subsidiary. Other than as disclosed in the Commission Documents
or the Disclosure Schedules, the Company does not own, directly or indirectly, any capital stock or other equity securities of any other
corporation or any ownership interest in any partnership, joint venture or other association. Each corporation, association or other
entity that is a “significant subsidiary” (within the meaning of Rule 1-02(w) of Regulation S-X) owned or controlled,
directly or indirectly, by the Company is set forth in the Commission Documents.


 






    	 	8	 



     

    

 


Section 5.2.          Authorization,
Enforcement. Each of the Company and the Operating Partnership has the requisite corporate
or other power and authority to enter into and perform its obligations under each of the Transaction Documents to which it is a party
and, in the case of the Company, to issue the Securities in accordance with the terms hereof and thereof. Except for approvals of the
Company’s Board of Directors or a committee thereof as may be required in connection with any issuance and sale of Shares to the
Investor hereunder (which approvals shall be obtained prior to the delivery of any VWAP Purchase Notice), the execution, delivery and
performance by the Company and the Operating Partnership of each of the Transaction Documents to which it is a party and the consummation
by it of the transactions contemplated hereby and thereby have been duly and validly authorized by all necessary corporate or other action
(as applicable) on the part of the Company and the Operating Partnership, and no further consent or authorization of (a) the Company
or its Board of Directors or its stockholders, (b) the Operating Partnership or any of its partners, or (c) any other Person
is required in order for each of the Company and the Operating Partnership to execute, deliver and perform its respective obligations
under the Transaction Documents to which it is a party. Each of the Transaction Documents to which the Company is a party has been duly
executed and delivered by the Company and constitutes a valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation, conservatorship, receivership or similar laws relating to, or affecting generally the enforcement of, creditor’s rights
and remedies or by other equitable principles of general application (including any limitation of equitable remedies). Each of the Transaction
Documents to which the Operating Partnership is a party has been duly executed and delivered by the Operating Partnership and constitutes
a valid and binding obligation of the Operating Partnership enforceable against the Operating Partnership in accordance with its terms,
except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship,
receivership or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by other
equitable principles of general application (including any limitation of equitable remedies).


 






    	 	9	 



     

    

 


Section 5.3.           Capitalization.
All the outstanding shares of capital stock of the Company and each of its Subsidiaries have been duly and validly authorized and
issued and are fully paid and non-assessable, and, except as otherwise set forth in the Commission Documents. Except as set forth in
the Commission Documents, this Agreement and the Registration Rights Agreement, there are no agreements or arrangements under which the
Company is obligated to register the sale of any securities under the Securities Act. Except as set forth in the Commission Documents,
no shares of capital stock of the Company are entitled to preemptive rights and there are no outstanding debt securities and no contracts,
commitments, understandings, or arrangements by which the Company is or may become bound to issue additional shares of the capital stock
of the Company or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or
securities or rights convertible into or exchangeable for, any shares of capital stock of the Company other than those issued or granted
in the ordinary course of business pursuant to the Company’s equity incentive and/or compensatory plans or arrangements. Except
as set forth in the Commission Documents, there are no securities or instruments containing anti-dilution or similar provisions that
will be triggered by this Agreement or any of the other Transaction Documents or the consummation of the transactions described herein
or therein. The Company has filed with the Commission true and correct copies of the Company’s Certificate of Incorporation as
in effect on the Closing Date (the “Charter”), and the Company’s Bylaws as in effect on the Closing Date
(the “Bylaws”). Except as disclosed in Exhibit A to the Seventh Amended and Restated Agreement of Limited
Partnership of the Operating Partnership (as amended, the “Partnership Agreement”), all of the outstanding
shares of capital stock or partner or member interests of the Subsidiaries are directly or indirectly owned of record and beneficially
by the Company, free and clear of any pledge, lien, encumbrance, security interest or other claim, except for security interests in favor
of lenders created pursuant to or in connection with loan documents disclosed in the Commission Documents and property-level financing.


 


Section 5.4.           Issuance
of Securities. The Shares to be issued under this Agreement have been, or with respect to
Shares to be purchased by the Investor pursuant to a particular VWAP Purchase Notice, will be, prior to the delivery to the Investor
hereunder of such VWAP Purchase Notice, duly authorized by all necessary corporate action on the part of the Company. As of the date
of this Agreement, 46,227,744 shares of Common Stock have been duly authorized and reserved by the Company for issuance and sale by the
Company to the Investor as Shares under this Agreement, collectively representing a number of shares equal to 19.99% of the shares of
Common Stock issued and outstanding immediately prior to the execution of this Agreement.


 


Section 5.5.           No
Conflicts. The execution, delivery and performance by each of the Company and the Operating
Partnership of each of the Transaction Documents to which it is a party and the consummation by the Company and the Operating Partnership
of the transactions contemplated hereby and thereby do not and shall not (i) result in a violation of any provision of the Company’s
Charter or Bylaws or the Partnership Agreement or other organizational documents of the Operating Partnership, (ii) conflict with
or result in a breach or violation of any of the terms or provisions of, or constitute a default (or an event which, with notice or lapse
of time or both, would become a default) under, or give rise to any rights of termination, amendment, acceleration or cancellation of,
any material agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the
Company, the Operating Partnership or any of the Company’s Subsidiaries is a party or is bound, (iii) create or impose a lien,
charge or encumbrance on any property or assets of the Company, the Operating Partnership or any of the Company’s Subsidiaries
under any agreement or any commitment to which the Company, the Operating Partnership or any of the Company’s Subsidiaries is a
party or by which the Company, the Operating Partnership or any of the Company’s Subsidiaries is bound or to which any of their
respective properties or assets is subject, or (iv) result in a violation of any federal, state, local or foreign statute, rule,
regulation, order, judgment or decree applicable to the Company, the Operating Partnership or any of the Company’s Subsidiaries
or by which any property or asset of the Company, the Operating Partnership or any of the Company’s Subsidiaries are bound or affected
(including federal and state securities laws and regulations and the rules and regulations of the Trading Market), except, in the
case of clauses (ii), (iii) and (iv), for such conflicts, defaults, terminations, amendments, acceleration, cancellations, liens,
charges, encumbrances and violations as would not, individually or in the aggregate, have a Material Adverse Effect. Except as specifically
contemplated by this Agreement or the Registration Rights Agreement and as required under the Securities Act and any applicable state
securities laws, neither the Company nor the Operating Partnership is required under any federal, state, local or foreign law, rule or
regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency
(including, without limitation, the Trading Market) in order for it to execute, deliver or perform any of its respective obligations
under the Transaction Documents to which it is a party, or to issue the Securities to the Investor in accordance with the terms hereof
and thereof (other than such consents, authorizations, orders, filings or registrations as have been obtained or made prior to the Closing
Date); provided, however, that, for purposes of the representation made in this sentence, each of the Company and the Operating
Partnership is assuming and relying upon the accuracy of the representations and warranties of the Investor in this Agreement and the
compliance by it with its covenants and agreements contained in this Agreement and the Registration Rights Agreement.


 






    	 	10	 



     

    

 


Section 5.6.           Commission
Documents, Financial Statements; Disclosure Controls and Procedures; Internal Controls Over Financial Reporting; Accountants.


 


(a)           The
Company has timely filed (giving effect to permissible extensions in accordance with Rule 12b-25 under the Exchange Act) all Commission
Documents for the twelve months preceding the date of this Agreement (the “Filed Commission Documents”). The
Company has delivered or made available to the Investor via EDGAR or otherwise true and complete copies of the Filed Commission Documents
(including, without limitation, the 2020 Form 10-K) prior to the Closing Date. As of its filing date, each SEC Filing (including,
without limitation, the 2020 Form 10-K) complied in all material respects with the requirements of the Securities Act or the Exchange
Act, as applicable, and other federal, state and local laws, rules and regulations applicable to it, and, as of its filing date
(or, if amended or superseded by a filing prior to the Closing Date, on the date of such amended or superseded filing). Each Registration
Statement, on the date it is filed with the Commission, on the date it is declared effective by the Commission, and at the time of delivery
of a VWAP Purchase Notice on the applicable VWAP Purchase Date, shall comply in all material respects with the requirements of the Securities
Act (including, without limitation, Rule 415 under the Securities Act) and shall not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading,
except that this representation and warranty shall not apply to statements in or omissions from such Registration Statement made in reliance
upon and in conformity with information relating to the Investor furnished to the Company in writing by or on behalf of the Investor
expressly for use therein. The Prospectus and each Prospectus Supplement required to be filed pursuant to this Agreement or the Registration
Rights Agreement after the Closing Date, when taken together, on its date, and at the time of delivery of a VWAP Purchase Notice on the
applicable VWAP Purchase Date, shall comply in all material respects with the requirements of the Securities Act (including, without
limitation, Rule 424(b) under the Securities Act) and shall not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading, except that this representation and warranty shall not apply to statements in or omissions
from the Prospectus or any Prospectus Supplement made in reliance upon and in conformity with information relating to the Investor furnished
to the Company in writing by or on behalf of the Investor expressly for use therein. Each Commission Document (other than the Initial
Registration Statement or any New Registration Statement, or the Prospectus included therein or any Prospectus Supplement thereto) to
be filed with or furnished to the Commission after the Closing Date and filed as part of or incorporated by reference in the Initial
Registration Statement or any New Registration Statement, or the Prospectus included therein or any Prospectus Supplement thereto required
to be filed pursuant to this Agreement or the Registration Rights Agreement (including, without limitation, the Current Report), when
such document is filed with or furnished to the Commission and, if applicable, when such document becomes effective, as the case may
be, shall comply in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and other federal,
state and local laws, rules and regulations applicable to it. There are no outstanding or unresolved comments or undertakings in
such comment letters received by the Company from the Commission. The Commission has not issued any stop order or other order suspending
the effectiveness of any registration statement filed by the Company under the Securities Act or the Exchange Act. To the Company’s
Knowledge, the Commission has not commenced any enforcement proceedings against the Company or any of its Subsidiaries.


 


(b)           The
financial statements and schedules of the Company and its consolidated Subsidiaries to be filed as part of or incorporated by reference
in the Initial Registration Statement or any New Registration Statement, or the Prospectus included therein or any Prospectus Supplement
thereto, present fairly in all material respects the financial condition, results of operations and cash flows of the Company and its
consolidated Subsidiaries as of the dates and for the periods indicated, comply as to form with the applicable accounting requirements
of Regulation S-X, and have been prepared in conformity with United States generally accepted accounting principles (“GAAP”)
applied on a consistent basis throughout the periods involved (except as otherwise noted therein). The interactive data in eXtensible
Business Reporting Language included or incorporated by reference in the Commission Documents, the Initial Registration Statement or
any New Registration Statement fairly present the information called for in all material respects and have been prepared in accordance
with the Commission’s rules and guidelines applicable thereto. The statistical and market-related data included or incorporated
by reference in the Commission Documents, the Initial Registration Statement or any New Registration Statement are based on or derived
from sources that the Company believes, after reasonable inquiry, to be reliable and accurate and, to the extent required, the Company
has obtained the written consent to the use of such data from such source.


 






    	 	11	 



     

    

 


(c)           The
Company, the Operating Partnership and the Subsidiaries have established and maintain disclosure controls and procedures (as such term
is defined in Rule 13a-15 and 15d-15 under the Exchange Act). Except as disclosed in Commission Documents, such disclosure controls
and procedures are designed to ensure that material information relating to the Company and its Subsidiaries is made known to the Company’s
Chief Executive Officer and its Chief Financial Officer by others within those entities, and such disclosure controls and procedures
are effective to perform the functions for which they were established. The Company, the Operating Partnership and the Subsidiaries have
established and maintain internal control over financial reporting (as such term is defined in Rule 13a-15 and 15d-15 under the
Exchange Act). Except as disclosed in Commission Documents, such internal control over financial reporting is designed to provide reasonable
assurance that (A) transactions are executed in accordance with management’s general or specific authorization; (B) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets;
(C) access to assets is permitted only in accordance with management’s general or specific authorization; (D) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences; and (E) the interactive data in eXtensible Business Reporting Language in the Commission Documents fairly presents
the information called for in all material respects and are prepared in accordance with the Commission’s rules and guidelines
applicable thereto. The Company’s auditors and the Audit Committee of the Board of Directors of the Company have been advised of:
(i) any significant deficiencies and material weaknesses in the design or operation of internal controls which could adversely affect
the Company’s ability to record, process, summarize, and report financial data; and (ii) any fraud, whether or not material,
that involves management or other employees who have a role in the Company’s internal controls. Since the date of the most recent
evaluation of such disclosure controls and procedures, except as disclosed in Commission Documents, there have been (A) no material
weakness in the Company’s internal control over financial reporting (whether or not remediated) and (B) no significant changes
in internal controls or in other factors that could significantly affect internal controls, including any corrective actions with regard
to significant deficiencies.


 


(d)           The
Company is in compliance with all provisions of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations thereunder,
which are applicable to it as of the date hereof.


 


(e)           The
Company’s accountants are set forth in the Commission Documents and, to the Knowledge of the Company, such accountants are an independent
registered public accounting firm as required by the Securities Act.


 


Section 5.7.           Due
Authorization of Partnership Agreement. The Partnership Agreement has been duly and validly
authorized, executed and delivered by or on behalf of the partners of the Operating Partnership and constitutes a valid and binding agreement
of the parties thereto, enforceable in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors’ rights generally or by general principles of equity.


 


Section 5.8.           Capitalization
of Operating Partnership. (A) Ashford OP Limited Partner, LLC (the “Limited
Partner”) is a holder of the common limited partnership interests in the Operating Partnership (the “Common
Units”) representing a majority limited partner ownership interest in the Operating Partnership and such units of preferred
limited partner interest in the Operating Partnership (the “Preferred Units”) as described in the Filed Commission
Documents, (B) Ashford OP General Partner, LLC (the “General Partner”) is the holder of the sole general
partner interest in the Operating Partnership, and (C) the Company owns a 100% member interest in the General Partner and in the
Limited Partner, in each case free and clear of any pledge, lien, encumbrance, security interest or other claim, except for security
interests in favor of lenders created pursuant to or in connection with loan documents disclosed in the Commission Documents. The Common
Units to be issued by the Operating Partnership to the Company in connection with the contribution of the cash proceeds from the sale
of the Shares to the Investor from time to time pursuant to this Agreement have been duly authorized and, when issued and delivered by
the Operating Partnership in accordance with the Partnership Agreement against payment therefor of the consideration set forth therein,
will be validly issued and non-assessable (except to the extent set forth in Section 17-303, 17-607 and 17-804 of the Delaware Revised
Uniform Limited Partnership Act). The holders of outstanding Common Units are not entitled pursuant to the Delaware Revised Uniform Limited
Partnership Act or the Partnership Agreement to preemptive or other rights to subscribe for the Securities or the Common Units to be
issued by the Operating Partnership to the Company in connection with the contribution of the cash proceeds from the sale of the Shares
to the Investor from time to time pursuant to this Agreement.


 



    	 	12	 



     

    




 


Section 5.9.           No
Material Adverse Effect or Material Adverse Change. Except as disclosed in the Commission
Documents, since December 31, 2020, there has not been (A) any change, or any development or event that would reasonably be
expected to result in a change, that has or would reasonably be expected to have a Material Adverse Effect, whether or not arising in
the ordinary course of business, (B) any transaction that is material to the Company and the Subsidiaries taken as a whole entered
into or agreed to be entered into by the Company or any of the Subsidiaries, (C) any obligation, contingent or otherwise, directly
or indirectly incurred by the Company or any Subsidiary that is material to the Company and Subsidiaries taken as a whole or (D) except
for regular quarterly dividends on the Common Stock and shares of the Company’s preferred stock, par value $0.01 per share, and
regular quarterly distributions on the Common Units and the Preferred Units, any dividend or distribution of any kind declared, paid
or made by the Company on any class of its capital stock or by the Operating Partnership on any of its partnership interests.


 


Section 5.10.         Mortgages.
The mortgages and deeds of trust encumbering any Real Property (as defined in Section 5.18) owned in fee or leased by the Company
or a Subsidiary (A) are not convertible (in the absence of foreclosure) into an equity interest in the Real Property or in the Company,
the Operating Partnership or any Subsidiary, and none of the Company, the Operating Partnership or the Subsidiaries hold a participating
interest therein, (B) except as set forth in the Commission Documents, are not and will not be cross-defaulted to any indebtedness
other than indebtedness of the Company or any of the Subsidiaries, and (C) are not and will not be cross-collateralized to any property
not owned by the Company, the Operating Partnership or any of the Subsidiaries.


 


Section 5.11.         Solvency.
The Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant to any Bankruptcy Law,
nor does the Company or the Operating Partnership have any Knowledge that the Company’s creditors intend to initiate involuntary
bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for relief under any Bankruptcy Law. The Company
is financially solvent and is generally able to pay its debts as they become due.


 






    	 	13	 



     

    

 


Section 5.12.         Property;
Real Property. The Company and the Subsidiaries have good and indefeasible title in fee
simple to, or a valid leasehold interest in, all Real Property described in the Commission Documents, and good title to all personal
property owned by them, in each case free and clear of all liens, security interests, pledges, charges, encumbrances, encroachments,
restrictions, mortgages and defects, except such as are disclosed in the Commission Documents or such as do not materially and adversely
affect the value of such property and do not interfere with the use made or proposed to be made of such property by the Company and the
Subsidiaries. Any Real Property, improvements, equipment and personal property held under lease by the Company or any Subsidiary are
held under valid, existing and enforceable leases, with such exceptions as are disclosed in the Commission Documents or are not material
and do not interfere with the use made or proposed to be made of such Real Property, improvements, equipment and personal property by
the Company or such Subsidiary. The Company or a Subsidiary has obtained an owner’s or leasehold title insurance policy, from a
title insurance company licensed to issue such policy, on any Real Property owned in fee or leased, as the case may be, by the Company
or any Subsidiary, that insures the Company’s or the Subsidiary’s fee or leasehold interest, as the case may be, in such
Real Property, which policies include only commercially reasonable exceptions, and with coverages in amounts at least equal to amounts
that are generally deemed in the Company’s industry to be commercially reasonable in the markets where the Company’s properties
are located, or a lender’s title insurance policy insuring the lien of its mortgage securing the Real Property with coverage equal
to the maximum aggregate principal amount of any indebtedness held by the Company or a Subsidiary and secured by the Real Property. All
Real Property owned or leased by the Company or a Subsidiary is free of material structural defects and all building systems contained
therein are in good working order in all material respects, subject to ordinary wear and tear or, in each instance, the Company has created
an adequate reserve to effect reasonably required repairs, maintenance and capital expenditures. To the Knowledge of the Company and
the Operating Partnership, water, storm water, sanitary sewer, electricity and telephone service are all available at the property lines
of such property over duly dedicated streets or perpetual easements of record benefiting such property. Except as described in the Commission
Documents, to the Knowledge of the Company and the Operating Partnership, there is no pending or threatened special assessment, tax reduction
proceeding or other action that, individually or in the aggregate, would reasonably be expected to increase or decrease the Real Property
taxes or assessments of any of such property, that, individually or in the aggregate, would reasonably be expected to have a Material
Adverse Effect.


 


Section 5.13.        Actions
Pending. Except as disclosed in Commission Documents, there is no action, suit, proceeding,
inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to
the Knowledge of the Company or the Operating Partnership, threatened against or affecting the Company or any of the Subsidiaries, or
any of their respective officers or directors in their capacities as such, which would reasonably be expected to have a Material Adverse
Effect.


 


Section 5.14.        Compliance
With Laws. During the 12-month period immediately preceding the date hereof, except as described
in the Filed Commission Documents, the Company and each of its Subsidiaries is and at all times has been in material compliance with
all applicable U.S. and foreign statutes, rules, or regulations applicable to Company and its Subsidiaries (“Applicable Laws”),
except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.


 


Section 5.15.         Certain
Fees. Except as set forth on Schedule 5.15, no brokerage or finder’s fees or commissions
are or will be payable by the Company, the Operating Partnership or any of the Subsidiaries to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents.
The Investor shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for
fees of a type contemplated in this Section 5.15 incurred by the Company, the Operating Partnership or any of the Subsidiaries that
may be due or payable in connection with the transactions contemplated by the Transaction Documents.


 



    	 	14	 



     

    




 


Section 5.16.        Disclosure.
Each of the Company and the Operating Partnership confirms that neither it nor any other Person acting on its behalf has provided the
Investor or any of its agents, advisors or counsel with any information that constitutes or could reasonably be expected to constitute
material, nonpublic information concerning the Company, the Operating Partnership or any of the Subsidiaries, other than the existence
of the transactions contemplated by the Transaction Documents. Each of the Company and the Operating Partnership understands and confirms
that the Investor will rely on the foregoing representations in effecting resales of Securities under the Registration Statement. All
disclosure provided to Investor regarding the Company, the Operating Partnership and the Subsidiaries, their businesses and the transactions
contemplated by the Transaction Documents (including, without limitation, the representations and warranties of the Company and the Operating
Partnership contained in the Transaction Documents to which it is a party (as modified by the Disclosure Schedule)) furnished in writing
by or on behalf of the Company or the Operating Partnership for purposes of or in connection with the Transaction Documents (other than
forward-looking information and projections and information of a general economic nature and general information about the Company’s
industry), taken together, is true and correct in all material respects on the date on which such information is dated or certified,
and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements
made therein, in the light of the circumstances under which they were made, not misleading at such time. Each press release issued by
the Company or any of its Subsidiaries during the 12 months preceding the Closing Date did not at the time of release (or, if amended
or superseded by a later dated press release issued by the Company or any of its Subsidiaries prior to the Closing Date or by a later
dated Commission Document filed with or furnished to the Commission by the Company prior to the Closing Date, at the time of issuance
of such later dated press release or filing or furnishing of such Commission Document, as applicable) contain any untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they are made, not misleading.


 


Section 5.17.        Regulatory
Permits. Each of the Company and the Subsidiaries has all necessary licenses, authorizations,
consents and approvals and has made all necessary filings required under any federal, state, local or foreign law, regulation or rule,
and has obtained all necessary authorizations, consents and approvals from other persons, required in order to conduct their respective
businesses as described in the Commission Documents, except to the extent that any failure to have any such licenses, authorizations,
consents or approvals, to make any such filings or to obtain any such authorizations, consents or approvals would not, individually or
in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of the Subsidiaries is in violation
of, in default under, or has received any written notice regarding a possible violation, default or revocation of any such license, authorization,
consent or approval or any federal, state, local or foreign law, regulation or rule or any decree, judgment or order applicable
to the Company or any of the Subsidiaries, the effect of which would reasonably be expected to result in a Material Adverse Effect. No
such license, authorization, consent or approval contains a materially burdensome restriction that is not adequately disclosed in the
Commission Documents. Neither the Company nor any of the Subsidiaries is required by any applicable law to obtain accreditation or certification
from any governmental agency or authority in order to provide the products and services that it currently provides or that it proposes
to provide as set forth in the Commission Documents, except to the extent that any failure to have such accreditation or certification
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. This Section 5.17 does not
relate to environmental matters, such items being the subject of Section 5.18.


 






    	 	15	 



     

    

 


Section 5.18.         Environmental
Compliance. Neither the Company nor any of the Subsidiaries is in violation, or has received
written notice of any violation with respect to, any applicable environmental, safety or similar law, regulation or rule applicable
to the business of the Company or any of the Subsidiaries, except any such violation of law, regulation or rule that individually
or in the aggregate, would not reasonably be expected to have a Material Adverse Effect. The Company and the Subsidiaries have received
all permits, licenses or other approvals required of them under applicable federal and state occupational safety and health and environmental
laws, regulations and rules to conduct their respective businesses, and the Company and the Subsidiaries are in compliance with
all terms and conditions of any such permit, license or approval, except any such violation of law, regulation or rule, failure to receive
required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals
that individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect. Except as otherwise disclosed
in the Commission Documents, (A) none of the Operating Partnership, the Company, any of the Subsidiaries nor, to the Knowledge of
the Operating Partnership and the Company, any other owners of the property at any time or any other party has at any time, handled,
stored, treated, transported, manufactured, spilled, leaked, or discharged, dumped, transferred or otherwise disposed of or dealt with,
Hazardous Materials (as hereinafter defined) on, in, under, to or from any real property leased, owned or controlled, including any real
property underlying any loan held or to be held by the Company or the Subsidiaries (collectively, the “Real Property”),
other than by any such action taken in compliance with all applicable Environmental Statutes (hereinafter defined) or by the Operating
Partnership, the Company, any of the Subsidiaries or any other party in connection with the ordinary use of residential, retail or commercial
properties owned by the Operating Partnership; (B) the Operating Partnership and the Company do not intend to use the Real Property
or any subsequently acquired properties for the purpose of using, handling, storing, treating, transporting, manufacturing, spilling,
leaking, discharging, dumping, transferring or otherwise disposing of or dealing with Hazardous Materials other than by any such action
taken in compliance with all applicable Environmental Statues or by the Operating Partnership, the Company, any of the Subsidiaries or
any other party in connection with the ordinary use of residential, retail or commercial properties owned by the Operating Partnership;
(C) none of the Operating Partnership, the Company, nor any of the Subsidiaries knows of any seepage, leak, discharge, release,
emission, spill, or dumping of Hazardous Materials into waters on or adjacent to the Real Property or any other real property owned or
occupied by any such party, or onto lands from which Hazardous Materials might seep, flow or drain into such waters; (D) none of
the Operating Partnership, the Company, nor any of the Subsidiaries has received any written notice of, or has any Knowledge of any occurrence
or circumstance that, with notice or passage of time or both, would give rise to a claim under or pursuant to any federal, state or local
environmental statute, regulation or rule or under common law, pertaining to Hazardous Materials on or originating from any of the
Real Property or any assets described in the Commission Documents or any other real property owned or occupied by any such party or arising
out of the conduct of any such party, including without limitation a claim under or pursuant to any Environmental Statute; (E) the
Real Property is not included or, to the Company’s and the Operating Partnership’s Knowledge, proposed for inclusion on the
National Priorities List issued pursuant to the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended,
42 U.S.C. Sections 9601-9675 (the “CERCLA”) by the United States Environmental Protection Agency or, to the
Operating Partnership’s and the Company’s Knowledge, proposed for inclusion on any similar list or inventory issued pursuant
to any other Environmental Statute or issued by any other Governmental Authority (as hereinafter defined); and (F) in the operation
of the Company’s and the Operating Partnership’s businesses, the Company acquires, before acquisition of any real property,
an environmental assessment of the real property and, to the extent they become aware of any condition that would reasonably be expected
to result in liability associated with the presence or release of a Hazardous Material, or any violation or potential violation of any
Environmental Statute, the Company and the Operating Partnership take all commercially reasonable action necessary or advisable (including
any capital improvements) for clean-up, closure or other compliance with such Environmental Statute. There are no costs or liabilities
associated with the Real Property pursuant to any Environmental Statute (including, without limitation, any capital or operating expenditures
required for clean-up, closure of properties or compliance with any Environmental Statute or any permit, license or approval, any related
constraints on operating activities and any potential liabilities to third parties) that, individually or in the aggregate, would reasonably
be expected to have a Material Adverse Effect. None of the entities that prepared Phase I or other environmental assessments with respect
to the Real Property was employed for such purpose on a contingent basis or has any substantial interest in the Company or any of the
Subsidiaries, and none of their directors, officers or employees is connected with the Company or any of the Subsidiaries as a promoter,
selling agent, trustee, officer, director or employee. None of the Operating Partnership, the Company nor any Subsidiary knows of any
violation of any municipal, state or federal law, rule or regulation (including those pertaining to environmental matters) concerning
the Real Property or any part thereof that, individually or in the aggregate, would reasonably be expected to have a Material Adverse
Effect. The Real Property complies with all applicable zoning laws, ordinances, regulations and deed restrictions or other covenants
in all material respects and, if and to the extent there is a failure to comply, such failure does not materially impair the value of
any of the Real Property and will not result in a forfeiture or reversion of title. None of the Operating Partnership, the Company nor
any Subsidiary has received from any governmental authority any written notice of any condemnation of or zoning change affecting the
Real Property or any part thereof, and none of the Operating Partnership, the Company nor any Subsidiary knows of any such condemnation
or zoning change which is threatened and which, individually or in the aggregate, if consummated would reasonably be expected to have
a Material Adverse Effect. All liens, charges, encumbrances, claims, or restrictions on or affecting the properties and assets (including
the Real Property) of the Operating Partnership or any of the Subsidiaries that are required to be described in the Commission Documents
are disclosed therein. No lessee of any portion of any of the Real Property is in default under any of the leases governing such properties
and there is no event which, but for the passage of time or the giving of notice or both would constitute a default under any of such
leases, except such defaults that individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.
No tenant under any lease pursuant to which the Operating Partnership or any of the Subsidiaries leases any Real Property has an option
or right of first refusal to purchase the premises leased thereunder or the building of which such premises are a part, except as such
options or rights of first refusal that, individually or in the aggregate, if exercised, would not reasonably be expected to have a Material
Adverse Effect. As used herein, “Hazardous Material” includes, without limitation any flammable explosives,
radioactive materials, hazardous materials, hazardous wastes, toxic substances, or related materials, asbestos or any hazardous material
as defined by any federal, state or local environmental law, regulation or rule including, without limitation, the CERCLA, the Hazardous
Materials Transportation Act, as amended, 49 U.S.C. Sections 1801-1819, the Resource Conservation and Recovery Act, as amended, 42 U.S.C.
Sections 6901-6992K, the Emergency Planning and Community Right-to-Know Act of 1986, 42 U.S.C. Sections 11001-11050, the Toxic Substances
Control Act, 15 U.S.C. Sections 2601-2671, the Federal Insecticide, Fungicide and Rodenticide Act, 7 U.S.C. Sections 136-136y, the Clean
Air Act, 42 U.S.C. Sections 7401-7642, the Clean Water Act (Federal Water Pollution Control Act), 33 U.S.C. Sections 1251-1387, the Safe
Drinking Water Act, 42 U.S.C. Sections 300f-300j-26, and the Occupational Safety and Health Act, 29 U.S.C. Sections 651-678, as any of
the above statutes may be amended from time to time, and in the regulations promulgated pursuant to each of the foregoing (individually,
an “Environmental Statute” and collectively the “Environmental Statutes”) or by any
federal, state or local governmental authority having or claiming jurisdiction over the properties and assets described in the Commission
Documents (a “Governmental Authority”).


 



    	 	16	 



     

    




 


Section 5.19.        Material
Agreements. Except as set forth in the Commission Documents, neither the Company nor any
Subsidiary of the Company is a party to any written or oral contract, instrument, agreement commitment, obligation, plan or arrangement,
a copy of which would be required to be filed with the Commission as an exhibit to an annual report on Form 10-K (collectively,
 “Material Agreements”). Each of the Material Agreements described in the Commission Documents conform in all
material respects to the descriptions thereof contained or incorporated by reference therein. Except as set forth in the Commission Documents,
the Company and each of its Subsidiaries have performed in all material respects all the obligations then required to be performed by
them under the Material Agreements, have received no notice of default or an event of default by the Company or any of its Subsidiaries
thereunder and are not aware of any basis for the assertion thereof, and neither the Company or any of its Subsidiaries nor, to the Knowledge
of the Company and the Operating Partnership, any other contracting party thereto are in default under any Material Agreement now in
effect, the result of which would have a Material Adverse Effect. Except as set forth in the Commission Documents, each of the Material
Agreements is in full force and effect, and constitutes a legal, valid and binding obligation enforceable in accordance with its terms
against the Company and/or any of its Subsidiaries and, to the Knowledge of the Company and the Operating Partnership, each other contracting
party thereto, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation,
conservatorship, receivership or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies
or by other equitable principles of general application.


 


Section 5.20.        Transactions
With Affiliates. Except as disclosed in the Commission Documents, none of the Company’s,
officers or directors, or to the Company’s or the Operating Partnership’s Knowledge, none of the Company’s stockholders
or any family member or affiliate of any of the foregoing, has either directly or indirectly an interest in, or is a party to, any transaction
that would be required to be disclosed as a related party transaction pursuant to Item 404 of Regulation S-K promulgated under the Securities
Act.


 


Section 5.21.         Intellectual
Property Rights. The Company and its Subsidiaries own or possess adequate rights or licenses
to use all material trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights,
inventions, licenses, approvals, governmental authorizations, trade secrets and rights necessary to conduct their respective businesses
as now conducted, except as would not reasonably be expected to have a Material Adverse Effect. None of the Company’s material
trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses,
approvals, government authorizations, trade secrets or other intellectual property rights have expired or terminated, or, by the terms
and conditions thereof, will expire or terminate within two years from the date of this Agreement, except as would not reasonably be
expected to have a Material Adverse Effect. Neither the Company nor the Operating Partnership has any Knowledge of any infringement by
the Company, the Operating Partnership or the Subsidiaries of any material trademark, trade name rights, patents, patent rights, copyrights,
inventions, licenses, service names, service marks, service mark registrations, trade secret or other similar rights of others, or of
any such development of similar or identical trade secrets or technical information by others, and there is no claim, action or proceeding
being made or brought against, or to the Company’s or the Operating Partnership’s Knowledge, being threatened against, the
Company, the Operating Partnership or the Subsidiaries regarding trademark, trade name, patents, patent rights, invention, copyright,
license, service names, service marks, service mark registrations, trade secret or other infringement, which would reasonably be expected
to have a Material Adverse Effect.


 






    	 	17	 



     

    

 


Section 5.22.         Use
of Proceeds. The proceeds from the sale of the Shares by the Company to the Investor shall
be used by the Company in the manner as will be set forth in the Prospectus included in any Registration Statement (and any post-effective
amendment thereto) and any Prospectus Supplement thereto filed pursuant to the Registration Rights Agreement.


 


Section 5.23.         Investment
Company Act Status. The Company is not required to be registered as, and immediately after
receipt of payment for the Shares will not be required to be registered as, an “investment company” within the meaning of
the Investment Company Act of 1940, as amended.


 


Section 5.24.        Benefit
Plans; Labor Matters. Each benefit and compensation plan, agreement, policy and arrangement
that is maintained, administered or contributed to by the Company for current or former employees or directors of, or independent contractors
with respect to, the Company has been maintained in material compliance with its terms and the requirements of any applicable statutes,
orders, rules and regulations, and the Company has complied in all material respects with all applicable statutes, orders, rules and
regulations in regard to such plans, agreements, policies and arrangements. Each stock option granted under any equity incentive plan
of the Company (each, a “Stock Plan”) was granted with a per share exercise price no less than the market price
per common share on the grant date of such option in accordance with the rules of the Trading Market, and no such grant involved
any “back-dating,” “forward-dating” or similar practice with respect to the effective date of such grant; each
such option (i) was granted in compliance in all material respects with Applicable Laws and with the applicable Stock Plan(s), (ii) was
duly approved by the Company’s Board of Directors, and (iii) has been properly accounted for in the Company’s financial
statements and disclosed, to the extent required, in the Company’s filings or submissions with the Commission, and the Trading
Market. Neither the Company nor any Subsidiary is in violation of or has received written notice of any violation with respect to any
federal or state law, regulation or rule relating to discrimination in the hiring, termination, promotion, employment or pay of
employees, nor any applicable federal or state wages and hours law, nor any state law, regulation or rule precluding the denial
of credit due to the neighborhood in which a property is situated, the violation of any of which, individually or in the aggregate, would
reasonably be expected to have a Material Adverse Effect. There are no existing or, to the Knowledge of the Company or the Operating
Partnership, threatened labor disputes with the employees of the Company or any of the Subsidiaries that would reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect.


 


Section 5.25.        Taxes.
  Each of the Company, the Operating Partnership and the Subsidiaries has filed on a timely basis (including in accordance with any
applicable extensions) all material necessary federal, state, local and foreign income and franchise tax returns required to be filed
through the date hereof or have properly requested extensions thereof, and have paid all taxes shown as due thereon, and if due and payable,
any related or similar assessment, fine or penalty levied against the Company, the Operating Partnership or any of the Subsidiaries.
Except as disclosed in the Commission Documents, no material tax deficiency has been asserted against any such entity, and neither the
Company nor the Operating Partnership have any Knowledge of any tax deficiency that is likely to be asserted against any such entity
that, individually or in the aggregate, if determined adversely to any such entity, would reasonably be expected to have a Material Adverse
Effect. All material tax liabilities are adequately provided for on the respective books of the Company and the Subsidiaries.


 


Section 5.26.         Insurance.
The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its
Subsidiaries are engaged, including, but not limited to, insurance covering real and personal property owned or leased by the Company
and the Subsidiaries against theft, damage, destruction, environmental liabilities, acts of vandalism, terrorism, earthquakes, flood
and all other risks customarily insured against, all of which insurance is in full force and effect. Neither the Company nor any such
Subsidiary has been refused any insurance coverage sought or applied for and neither the Company nor any such Subsidiary has any reason
to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business at a cost that would not reasonably be expected to have a Material
Adverse Effect.


 


Section 5.27.         Exemption
from Registration. Subject to, and in reliance on, the representations, warranties and covenants
made herein by the Investor, the offer and sale of the Securities to the Investor in accordance with the terms and conditions of this
Agreement is exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2); provided, however,
that at the request of and with the express agreements of the Investor (including, without limitation, the representations, warranties
and covenants of Investor set forth in Section 4.9 through 4.13), the Securities to be issued from and after Commencement to or
for the benefit of the Investor pursuant to this Agreement shall be issued to the Investor or its designee only as DWAC Shares and will
not bear legends noting restrictions as to resale of such securities under federal or state securities laws, nor will any such securities
be subject to stop transfer instructions.


 



    	 	18	 



     

    




Section 5.28.         No
General Solicitation or Advertising. None of the Company, its Subsidiaries or the Operating
Partnership, or any of their respective Affiliates, or any Person acting on its or their behalf, has engaged in any form of general solicitation
or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Securities.


 


Section 5.29.         No
Integrated Offering. None of the Company, its Subsidiaries or the Operating Partnership,
or any of their respective Affiliates, or any Person acting on its or their behalf, has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under circumstances that would require registration of the issuance of any
of the Securities under the Securities Act, whether through integration with prior offerings or otherwise, or cause this offering of
the Securities to require approval of stockholders of the Company under any applicable stockholder approval requirements under Maryland
law, any stockholder approval provisions of the Charter or the Bylaws, or under applicable rules of the Trading Market. None of
the Company, its Subsidiaries or the Operating Partnership, or any of their respective Affiliates, or any Person acting on its or their
behalf, will take any action or steps referred to in the preceding sentence that would require registration of the issuance of any of
the Securities under the Securities Act or cause the offering of any of the Securities to be integrated with other offerings.


 


Section 5.30.        Dilutive
Effect. The Company is aware and acknowledges that issuance of the Securities could cause
dilution to existing stockholders and could significantly increase the outstanding number of shares of Common Stock. The Company further
acknowledges that its obligation to issue the Shares pursuant to the terms of a VWAP Purchase in accordance with this Agreement is, in
each case, absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of other
stockholders of the Company.


 


Section 5.31.        Manipulation
of Price. The Company has not, and to its knowledge no Person acting on its behalf has,
(i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of
any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any
compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for
soliciting another to purchase any other securities of the Company. Neither the Company nor any of its officers, directors or Affiliates
will during the term of this Agreement, and, to the Knowledge of the Company, no Person acting on their behalf will during the term of
this Agreement, take any of the actions referred to in the immediately preceding sentence.


 


Section 5.32.         Securities
Act. Except as set forth in the Disclosure Schedule, the Company has complied and shall
comply with all applicable federal and state securities laws in connection with the offer, issuance and sale of the Securities hereunder,
including, without limitation, the applicable requirements of the Securities Act. Each Registration Statement, upon filing with the Commission
and at the time it is declared effective by the Commission, shall satisfy all of the requirements of the Securities Act to register the
resale of the Registrable Securities included therein by the Investor in accordance with the Registration Rights Agreement on a delayed
or continuous basis under Rule 415 under the Securities Act at then-prevailing market prices, and not fixed prices. The Company
is not, and has not previously been at any time, an issuer identified in, or subject to, Rule 144(i).


 



    	 	19	 



     

    







 



 


Section 5.33.         Listing
and Maintenance Requirements; DTC Eligibility. The Common Stock is registered pursuant to
Section 12(b) of the Exchange Act, and the Company has taken no action designed to, or which to its Knowledge is likely to
have the effect of, terminating the registration of the Common Stock pursuant to the Exchange Act nor has the Company received any notification
that the Commission is currently contemplating terminating such registration. Except as disclosed in the Filed Commission Documents,
the Company has not, in the twelve (12) months preceding the date hereof, received any written notice from any Person to the effect that
the Company is not in compliance with the listing or maintenance requirements of the Trading Market. Except as disclosed in the Commission
Documents, the Company is in compliance with all such listing and maintenance requirements of the Trading Market. The Common Stock is
eligible for participation in the DTC book entry system and has shares on deposit at DTC for transferred electronically to third parties
via DTC through its Deposit/Withdrawal at Custodian (“DWAC”) delivery system. The Company has not received
notice from DTC to the effect that a suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic
trading or book-entry services by DTC with respect to the Common Stock is being imposed or is contemplated.


 


Section 5.34.         Application
of Takeover Protections. The Company and its Board of Directors have taken all necessary
action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or other similar anti-takeover provision under the Company’s Charter or the laws of the State of Maryland
that is or could become applicable to the Investor as a result of the Investor and the Company fulfilling their respective obligations
or exercising their respective rights under the Transaction Documents (as applicable), including, without limitation, as a result of
the Company’s issuance of the Securities and the Investor’s ownership of the Securities.


 


Section 5.35.         Foreign
Corrupt Practices. Neither the Company, the Operating Partnership or any Subsidiary, nor
to the Knowledge of the Company or the Operating Partnership, any agent or other Person acting on behalf of the Company or the Operating
Partnership, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses
related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or
employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any
contribution made by the Company or the Operating Partnership (or made by any Person acting on its behalf of which the Company is aware)
which is in violation of law, or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977,
as amended (the “FCPA”).


 


Section 5.36.         Money
Laundering Laws. The operations of the Company and its Subsidiaries are and have been conducted
at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and
any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the
 “Money Laundering Laws”); and no action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or,
to the Knowledge of the Company, threatened.


 






    	 	20	 



     

    

 


Section 5.37.        OFAC.
Neither the Company nor any of its Subsidiaries nor, to the Knowledge of the Company, any director, officer, agent, employee or Affiliate
of the Company or any of its Subsidiaries (i) is currently subject to any sanctions administered by the U.S. government, including
the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”) or the U.S. Department of State,
the United Nations Security Council, the European Union, or the United Kingdom (including sanctions administered or controlled by Her
Majesty’s Treasury) (collectively, “Sanctions” and such persons, “Sanctioned Persons”)
or other relevant sanctions authority, and (ii) will use the proceeds of this offering, directly or indirectly, to fund or facilitate
the activities of any Sanctioned Persons or entity or any country, region or territory that is, at the time of such funding or facilitation,
subject to Sanctions or any person or entity located in a country, region or territory subject to Sanctions (including any administered
or enforced by OFAC or the U.S. Department of State), the United Nations Security Council, the European Union, or the United Kingdom
(including sanctions administered or controlled by Her Majesty’s Treasury). Neither the Company nor any of its subsidiaries nor,
to the Knowledge of the Company, any director, officer, agent, employee or Affiliate of the Company or any of its subsidiaries, is a
person that is, or is 50% or more owned or otherwise controlled by a person that is: (i) the subject of any Sanctions; or (ii) located,
organized or resident in a country, region or territory that is, or whose government is, the subject of Sanctions that broadly prohibit
dealings with that country, region or territory (including at the time of this agreement, Cuba, Iran, North Korea, Syria and Crimea)
(collectively, “Sanctioned Countries” and each, a “Sanctioned Country”). The Company
and its Subsidiaries have not engaged in any dealings or transactions with or for the benefit of Sanctioned Persons, or with or in a
Sanctioned Country, in the preceding 3 years, nor does the Company or any of its subsidiaries have any plans to deal or transact with
Sanctioned Persons, or with or in Sanctioned Countries.


 


Section 5.38.         Information
Technology; Compliance With Data Privacy Laws. (i) There have been no material breaches
or violations of (or unauthorized access to) the Company, the Operating Partnership’s or the Subsidiaries’ information technology
assets and equipment, computers, systems, networks, hardware, software, websites, applications and databases (collectively, the “IT
Systems”) or any personal, personally identifiable, sensitive, confidential or regulated data (collectively, “Personal
Data”) processed or stored by or on behalf of the Company, the Operating Partnership or the Subsidiaries, except for those
that have been remedied without material cost or liability or the duty to notify any regulator, nor are there any pending internal investigations
of the Company, the Operating Partnership or the Subsidiaries relating to the same and (ii) the Company, the Operating Partnership
and the Subsidiaries are presently in compliance in all material respects with all applicable laws, statutes and regulations and contractual
obligations relating to the privacy and security of IT Systems and Personal Data.


 


Section 5.39.         No
Disqualification Events. None of the Company, the Operating Partnership, any of their predecessors,
any affiliated issuer, any director, general partner executive officer, other officer of the Company or the Operating Partnership participating
in the offering contemplated hereby, any beneficial owner of 20% or more of the Company’s outstanding voting equity securities,
calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected
with the Company or the Operating Partnership in any capacity at the time of sale (each, an “Issuer Covered Person”)
is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the
Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or
(d)(3) under the Securities Act. The Company and the Operating Partnership have exercised reasonable care to determine whether any
Issuer Covered Person is subject to a Disqualification Event.


 


Section 5.40.        REIT
Status. Commencing with the Company’s taxable year ended December 31, 2003, the
Company has been organized and operated in conformity with the requirements for qualification as a real estate investment trust (a “REIT”)
under the Code, and the current and proposed method of operation of the Company and the Subsidiaries described in the Commission Documents
will enable the Company to meet the requirements for qualification and taxation as a REIT under the Code, and the Operating Partnership
is treated as a partnership for federal income tax purposes and not as a corporation or association taxable as a corporation; the Company
intends to continue to qualify as a REIT for all subsequent years, and neither the Company nor the Operating Partnership has any Knowledge
of any event that would reasonably be expected to cause the Company to fail to qualify as a REIT at any time.


 






    	 	21	 



     

    

 


Section 5.41.        Authorization
of Advisory Agreement. The Second Amended and Restated Advisory Agreement, dated January 14,
2021, by and among the Company, the Operating Partnership, Ashford Hospitality Advisors LLC, a Delaware limited liability company, Ashford
TRS Corporation and Ashford Inc., which amends and restates the terms of the Amended and Restated Advisory Agreement, dated as of June 10,
2015, as amended by the Enhanced Return Funding Program Agreement and Amendment No. 1 to the Amended and Restated Advisory Agreement,
dated as of June 26, 2018, has been duly authorized, executed and delivered by the Company and the Operating Partnership and constitutes
a legal, valid and binding agreement of the Company and the Operating Partnership enforceable against the Company and the Operating Partnership
in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
creditors’ rights generally, and by general principles of equity.


 


Section 5.42.         Acknowledgement
Regarding Investor’s Acquisition of Securities. Each of the Company and the Operating
Partnership acknowledges and agrees that the Investor is acting solely in the capacity of an arm’s-length purchaser with respect
to this Agreement and the transactions contemplated by the Transaction Documents. Each of the Company and the Operating Partnership further
acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company or the Operating Partnership (or in any
similar capacity) with respect to this Agreement and the transactions contemplated by the Transaction Documents, and any advice given
by the Investor or any of its representatives or agents in connection therewith is merely incidental to the Investor’s acquisition
of the Securities. Each of the Company and the Operating Partnership further represents to the Investor that the Company’s and
the Operating Partnership’s decision to enter into the Transaction Documents to which it is a party has been based solely on the
independent evaluation of the transactions contemplated thereby by the Company and the Operating Partnership, respectively, and their
respective representatives. Each of the Company and the Operating Partnership acknowledges and agrees that the Investor has not made
and does not make any representations or warranties with respect to the transactions contemplated by the Transaction Documents other
than those specifically set forth in Article IV.


 


Article VI

ADDITIONAL COVENANTS


 


Each of the Company and the
Operating Partnership, jointly and severally, covenants with the Investor, and the Investor covenants with the Company and the Operating
Partnership, as follows, which covenants of the Company and the Operating Partnership, jointly and severally, are for the benefit of
the Investor and which covenants of the Investor are for the benefit of the Company and the Operating Partnership, during the Investment
Period (and with respect to the Company and the Operating Partnership, jointly and severally, for the period following the termination
of this Agreement specified in Section 8.3 pursuant to and in accordance with Section 8.3):


 


Section 6.1.           Securities
Compliance. The Company shall notify the Commission and the Trading Market, if and as applicable,
in accordance with their respective rules and regulations, of the transactions contemplated by the Transaction Documents, and shall
take all necessary action, undertake all proceedings and obtain all registrations, permits, consents and approvals for the legal and
valid issuance of the Securities to the Investor in accordance with the terms of the Transaction Documents, as applicable.


 


Section 6.2.           Reservation
of Common Stock. The Company has available and the Company shall reserve and keep available
at all times, free of preemptive and other similar rights of stockholders, the requisite aggregate number of authorized but unissued
shares of Common Stock to enable the Company to timely effect the issuance, sale and delivery of all Shares pursuant to this Agreement.
Without limiting the generality of the foregoing, as of the date of this Agreement the Company has reserved, and as of the Commencement
Date shall have continued to reserve, out of its authorized and unissued Common Stock, 46,227,744 shares of Common Stock solely for the
purpose of effecting VWAP Purchases under this Agreement. The number of shares of Common Stock so reserved for the purpose of effecting
VWAP Purchases under this Agreement may be increased from time to time by the Company from and after the Commencement Date, and such
number of reserved shares may be reduced from and after the Commencement Date only by the number of Shares actually issued, sold and
delivered to the Investor pursuant to any VWAP Purchase effected from and after the Commencement Date pursuant to this Agreement.


 


Section 6.3.
          Registration and
Listing. The Company shall use its commercially reasonable efforts to cause the Common Stock
to continue to be registered as a class of securities under Sections 12(b) of the Exchange Act, and to comply with its reporting
and filing obligations under the Exchange Act, and shall not take any action or file any document (whether or not permitted by the Securities
Act or the Exchange Act) to terminate or suspend such registration or to terminate or suspend its reporting and filing obligations under
the Exchange Act or Securities Act, except as permitted herein. The Company shall use its commercially reasonable efforts to continue
the listing and trading of its Common Stock and the listing of the Securities purchased by the Investor hereunder on the Trading Market
and to comply with the Company’s reporting, filing and other obligations under the rules and regulations of the Trading Market.
The Company shall not take any action which could be reasonably expected to result in the delisting or suspension of the Common Stock
on the Trading Market. If the Company receives any final and non-appealable notice that the listing or quotation of the Common Stock
on the Trading Market shall be terminated on a date certain, the Company shall promptly (and in any case within 24 hours) notify the
Investor of such fact in writing and shall use its commercially reasonable efforts to cause the Common Stock to be listed or quoted on
another Eligible Market.


 






    	 	22	 



     

    

 


Section 6.4.           Compliance
with Laws.


 


(i)            During
the Investment Period, (a) each of the Company and the Operating Partnership shall comply, and the Company shall cause each Subsidiary
to comply, with all laws, rules, regulations and orders applicable to the business and operations of the Company, the Operating Partnership
and the Subsidiaries, except as would not have a Material Adverse Effect, and (b) the Company shall comply with all applicable provisions
of the Securities Act and the Exchange Act, including Regulation M thereunder, applicable state securities or “Blue Sky”
laws, and applicable listing rules of the Trading Market or Eligible Market, except as would not, individually or in the aggregate,
prohibit or otherwise interfere with the ability of the Company to enter into and perform its obligations under this Agreement in any
material respect or for Investor to conduct resales of Securities under the Registration Statement in any material respect. Without limiting
the foregoing, none of the Company, the Operating Partnership, or any of the Subsidiaries, nor to the Knowledge of the Company and the
Operating Partnership, any of their respective directors, officers, agents, employees or any other Persons acting on their behalf shall,
in connection with the operation of the respective businesses of the Company, the Operating Partnership and the Subsidiaries, (1) use
any corporate funds for unlawful contributions, payments, gifts or entertainment or to make any unlawful expenditures relating to political
activity to government officials, candidates or members of political parties or organizations, (2) pay, accept or receive any unlawful
contributions, payments, expenditures or gifts, or (3) violate or operate in noncompliance with any export restrictions, anti-boycott
regulations, embargo regulations or other applicable domestic or foreign laws and regulations, including, without limitation, the FCPA
and the Money Laundering Laws.


 


(ii)            The
Investor shall comply with all laws, rules, regulations and orders applicable to the performance by it of its obligations under this
Agreement and its investment in the Securities, except as would not, individually or in the aggregate, prohibit or otherwise interfere
with the ability of the Investor to enter into and perform its obligations under this Agreement in any material respect. Without limiting
the foregoing, the Investor shall comply with all applicable provisions of the Securities Act and the Exchange Act, including Regulation
M thereunder, and all applicable state securities or “Blue Sky” laws.


 


Section 6.5.           Keeping
of Records and Books of Account; Due Diligence.


 


(i)             The
Investor and the Company shall each maintain records showing the remaining Total Purchase Commitment, the remaining Aggregate Limit and
the dates and VWAP Purchase Share Amount for each VWAP Purchase.


 


(ii)            Subject
to the requirements of Section 6.12, the Investor shall have the right, from time to time as the Investor may reasonably deem appropriate,
and upon reasonable advance notice to the Company, to perform reasonable due diligence on the Company and the Operating Partnership during
normal business hours; provided, however, that after the Closing Date, the Investor’s continued due diligence of the Company and
the Operating Partnership shall not be a condition precedent to, or otherwise impair, delay or modify in any respect, the Company’s
right to deliver to the Investor any VWAP Purchase Notice, or the Investor’s obligation to purchase the Shares subject thereto,
pursuant to this Agreement. The Company and its officers and employees shall provide information on a reasonably timely basis and otherwise
reasonably cooperate with the Investor in connection with any reasonable request by the Investor related to the Investor’s due
diligence of the Company and the Operating Partnership.


 



    	 	23	 



     

    




 


Section 6.6.           No
Frustration; No Dilutive Issuances During and Prior to Settlement of any VWAP Purchase.


 


(i)            No
Frustration. Neither the Company nor the Operating Partnership shall enter into, announce or recommend to the Company’s stockholders
any agreement, plan, arrangement or transaction in or of which the terms thereof would restrict, materially delay, conflict with or impair
the ability or right of the Company or the Operating Partnership to perform its obligations under the Transaction Documents to which
it is a party, including, without limitation, the obligation of the Company to deliver the Shares to the Investor in respect of an VWAP
Purchase as DWAC Shares not later than 1:00 p.m., New York City time, on the applicable VWAP Purchase Share Delivery Date for such VWAP
Purchase in accordance with Section 3.2 of this Agreement. For the avoidance of doubt, nothing in this Section 6.6(i) shall
in any way limit the Company’s right to terminate this Agreement in accordance with Section 8.2 (subject in all cases to Section 8.3).


 


(ii)            No
Dilutive Issuances During and Prior to Settlement of any VWAP Purchase. None of the Company, the Operating Partnership or any
Subsidiary shall issue, sell or grant any right, option or warrant to purchase, or issue, sell or grant any right to reprice (or reset
the purchase price therefor), or otherwise dispose of for cash (or enter into any agreement, plan or arrangement contemplating any of
the foregoing, or seek to utilize any existing agreement, plan or arrangement to effect any of the foregoing), or announce any offer,
issuance, sale or grant of any option or warrant to purchase or other disposition for cash (or any agreement, plan or arrangement therefor),
at any time during the period beginning at 5:30 p.m., New York City time, on the Trading Day immediately preceding a VWAP Purchase Date
under this Agreement, and ending at 5:30 p.m., New York City time, on the Trading Day immediately following the Trading Day on which
the Investor shall have received, as DWAC Shares, all of the Shares purchased by the Investor pursuant to such VWAP Purchase Notice for
such VWAP Purchase (each such period, a “Reference Period”), any Common Stock or Common Stock Equivalents,
at an effective price per share of Common Stock less than the applicable VWAP Purchase Price per Share (such price, the “Reference
Price”) to be sold to the Investor in the applicable VWAP Purchase to which such Reference Period relates (each such issuance,
a “Dilutive Issuance”), other than an Exempt Issuance (it being understood and agreed that if the holder of
the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection
with such issuance, be entitled to receive shares of Common Stock at an effective price per share of Common Stock that is less than the
applicable Reference Price, such issuance shall be deemed to have occurred for less than the applicable Reference Price on such date
of the Dilutive Issuance at such effective price). If the Company enters into a Variable Rate Transaction, the Company shall be deemed
to have issued Common Stock or Common Stock Equivalents at the lowest possible conversion or exercise price at which such securities
may be converted or exercised. The Investor shall be entitled to seek injunctive relief against the Company, the Operating Partnership
and the Subsidiaries to preclude any such Dilutive Issuance that does not constitute an Exempt Issuance, which remedy shall be in addition
to any right to collect damages, without the necessity of showing economic loss and without any bond or other security being required.
For the avoidance of doubt, other than as may be restricted or prohibited under the terms of this Agreement, including as set forth in
Section 6.7 or Section 6.8 of this Agreement or in subsection (i) or (ii) of this Section 6.6, the Company may,
during the term of this Agreement and thereafter, issue and allot, or undertake to issue and allot, any shares and/or securities and/or
convertible notes, bonds, debentures, options to acquire shares or other securities and/or other facilities which may be converted into
or replaced by Common Stock or other securities of the Company, and may extend, renew and/or recycle any bonds and/or debentures, and/or
grant any rights with respect to its existing and/or future share capital.


 



    	 	24	 



     

    




 


Section 6.7.           Corporate
Existence. Each of the Company and the Operating Partnership shall take all steps necessary
to preserve and continue the corporate existence of the Company; provided, however, that, except as provided in Section 6.8, nothing
in this Agreement shall be deemed to prohibit the Company from engaging in any Fundamental Transaction with another Person. For the avoidance
of doubt, nothing in this Section 6.7 shall in any way limit the Company’s right to terminate this Agreement in accordance
with Section 8.2 (subject in all cases to Section 8.3).


 


Section 6.8.
           Fundamental Transaction.
If a VWAP Purchase Notice has been delivered by the Company to the Investor under Article III and the applicable VWAP Purchase has
not yet been fully settled in accordance with this Agreement (including, without limitation, the delivery by the Investor to the Company
of the applicable total purchase price for all of the Shares purchased by the Investor in such VWAP Purchase as contemplated by Section 3.2),
the Company shall not effect any Fundamental Transaction until the expiration of three (3) Trading Days following the Trading Day
on which the VWAP Purchase has been fully settled in accordance with this Agreement (which, for the avoidance of doubt shall be the first
Trading Day on which all of the Shares purchased by the Investor thereunder shall have been received by the Investor as DWAC Shares,
and the Investor shall have delivered to the Company the applicable total VWAP Purchase Price for all such Shares purchased by the Investor
thereunder, in each case in accordance with Section 3.2).


 


Section 6.9.           Selling
Restrictions.


 


(i)             Except
as expressly set forth below, the Investor covenants that from and after the Closing Date through and including the Trading Day next
following the expiration or termination of this Agreement (the “Restricted Period”), neither the Investor nor
any of its Affiliates nor any entity managed or controlled by the Investor (collectively, the “Restricted Persons”
and each of the foregoing is referred to herein as a “Restricted Person”) shall, directly or indirectly, (x) engage
in any Short Sales involving the Company’s securities or (y) grant any option to purchase, or acquire any right to dispose
of or otherwise dispose for value of, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for
any shares of Common Stock, or enter into any swap, hedge or other similar agreement that transfers, in whole or in part, the economic
risk of ownership of the Common Stock. Notwithstanding the foregoing, it is expressly understood and agreed that nothing contained herein
shall (without implication that the contrary would otherwise be true) prohibit any Restricted Person during the Restricted Period
from: (1) selling “long” (as defined under Rule 200 promulgated under Regulation SHO) the Securities; or (2) selling a
number of shares of Common Stock equal to the number of Shares that such Restricted Person is unconditionally obligated to purchase
under a pending VWAP Purchase Notice but has not yet received from the Company or the Transfer Agent pursuant to this Agreement,
so long as (X) such Restricted Person (or the Broker-Dealer, as applicable) delivers the Shares purchased pursuant to such VWAP
Purchase Notice to the purchaser thereof or the applicable Broker-Dealer promptly upon such Restricted Person’s receipt of such
Shares from the Company in accordance with Section 3.2 of this Agreement and (Y) neither the Company or the Transfer Agent
shall have failed for any reason to deliver such Shares to the Investor or its Broker-Dealer so that such Shares are received by the
Investor as DWAC Shares on the applicable VWAP Purchase Share Delivery Date in accordance with Section 3.2 of this Agreement, including,
without limitation, within the time period specified for receipt of such Shares by the Investor or its Broker-Dealer as DWAC Shares from
the Company or the Transfer Agent.


 



    	 	25	 



     

    




 


(ii)            In
addition to the foregoing, in connection with any sale of Securities (including any sale permitted by paragraph (i) above), the
Investor shall comply in all respects with all applicable laws, rules, regulations and orders, including, without limitation, the requirements
of the Securities Act and the Exchange Act.


 


Section 6.10.         Effective
Registration Statement. During the Investment Period, the Company shall use its commercially
reasonable efforts to maintain the continuous effectiveness of the Initial Registration Statement and each New Registration Statement
filed with the Commission under the Securities Act for the applicable Registration Period pursuant to and in accordance with the Registration
Rights Agreement.


 


Section 6.11.        Blue
Sky. The Company shall take such action, if any, as is necessary by the Company in order
to obtain an exemption for or to qualify the Securities for sale by the Company to the Investor pursuant to the Transaction Documents,
and at the request of the Investor, the subsequent resale of Registrable Securities by the Investor, in each case, under applicable state
securities or “Blue Sky” laws and shall provide evidence of any such action so taken to the Investor from time to time following
the Closing Date; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify
to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 6.11, (y) subject
itself to general taxation in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction.


 


Section 6.12.         Non-Public
Information. None of the Company, the Operating Partnership or any of the Subsidiaries,
nor any of their respective directors, officers, employees or agents shall disclose any material non-public information about the Company,
the Operating Partnership or the Subsidiaries to the Investor, unless a simultaneous public announcement thereof is made by the Company
in the manner contemplated by Regulation FD. In the event of a breach of the foregoing covenant by the Company, the Operating Partnership
or any of the Subsidiaries, or any of their respective directors, officers, employees and agents (as determined in the reasonable good
faith judgment of the Investor), (i) the Investor shall promptly provide written notice of such breach to the Company and (ii) after
such notice has been provided to the Company and, provided that the Company shall have failed to publicly disclose such material, non-public
information within 24 hours following demand therefor by the Investor, in addition to any other remedy provided herein or in the other
Transaction Documents, the Investor shall have the right to make a public disclosure, in the form of a press release, public advertisement
or otherwise, of such material, non-public information without the prior approval by the Company, the Operating Partnership, any of the
Subsidiaries, or any of their respective directors, officers, employees or agents. The Investor shall not have any liability to the Company,
the Operating Partnership, any of the Subsidiaries, or any of their respective directors, officers, employees, stockholders or agents,
for any such disclosure.


 


 


Section 6.13.         Broker/Dealer.
The Investor shall use one or more broker-dealers to effectuate all sales, if any, of the Shares that it may purchase or otherwise acquire
from the Company pursuant to the Transaction Documents, as applicable, which (or whom) shall be not then currently engaged or used by
the Company, and a DTC participant (collectively, the “Broker-Dealer”). The Investor shall, from time to time,
provide the Company and the Transfer Agent with all information regarding the Broker-Dealer reasonably requested by the Company. The
Investor shall be solely responsible for all fees and commissions of the Broker-Dealer, which shall not exceed customary brokerage fees
and commissions and shall be responsible for designating only a DTC participant eligible to receive DWAC Shares.


 


Section 6.14.         Disclosure
Schedule.


 


(i)             The
Company may, from time to time, update the Disclosure Schedule as may be required to satisfy the conditions set forth in Section 7.2(i) and
Section 7.3(i) (to the extent such condition set forth in Section 7.3(i) relates to the condition in Section 7.2(i) as
of a specific VWAP Purchase Condition Satisfaction Time). For purposes of this Section 6.14, any disclosure made in a schedule to
the Compliance Certificate shall be deemed to be an update of the Disclosure Schedule. Notwithstanding anything in this Agreement to
the contrary, no update to the Disclosure Schedule pursuant to this Section 6.14 shall cure any breach of a representation or warranty
of the Company or the Operating Partnership contained in this Agreement and made prior to the update and shall not affect any of the
Investor’s rights or remedies with respect thereto.


 


(ii)            Notwithstanding
anything to the contrary contained in the Disclosure Schedule or in this Agreement, the information and disclosure contained in any Schedule
of the Disclosure Schedule shall be deemed to be disclosed and incorporated by reference in any other Schedule of the Disclosure Schedule
as though fully set forth in such Schedule for which applicability of such information and disclosure is reasonably apparent. The fact
that any item of information is disclosed in the Disclosure Schedule shall not be construed to mean that such information is required
to be disclosed by this Agreement. Except as expressly set forth in this Agreement, such information and the thresholds (whether based
on quantity, qualitative characterization, dollar amounts or otherwise) set forth herein shall not be used as a basis for interpreting
the terms “material” or “Material Adverse Effect” or other similar terms in this Agreement.


 






    	 	26	 



     

    

 


Section 6.15.         Delivery
of Bring Down Opinions and Compliance Certificates Upon Occurrence of Certain Events. Within
three (3) Trading Days immediately following (i) the end of each PEA Period, if the Company is required under the Securities
Act to file with the Commission (A) a post-effective amendment to the Initial Registration Statement required to be filed by the
Company with the Commission pursuant to Section 2(a) of the Registration Rights Agreement, (B) a New Registration Statement
required to be filed by the Company with the Commission pursuant to Section 2(c) of the Registration Rights Agreement, or (C) a
post-effective amendment to a New Registration Statement required to be filed by the Company with the Commission pursuant to Section 2(c) of
the Registration Rights Agreement, in each case with respect to a fiscal year ending after the Commencement Date, to register the resale
of Securities by the Investor under the Securities Act pursuant to this Agreement and the Registration Rights Agreement, and (ii) the
date the Company files with the Commission (A) a Prospectus Supplement to the Prospectus contained in the Initial Registration Statement
or any New Registration Statement under the Securities Act, (B) an annual report on Form 10-K under the Exchange Act with respect
to a fiscal year ending after the Commencement Date, (C) an amendment on Form 10-K/A to an annual report on Form 10-K
under the Exchange Act with respect to a fiscal year ending after the Commencement Date, which contains amended material financial information
(or a restatement of material financial information) or an amendment to other material information contained in a previously filed Form 10-K,
and (D) a Commission Document under the Exchange Act (other than those referred to in clauses (ii)(A) and (ii)(B) of this
Section 6.15), which contains amended material financial information (or a restatement of material financial information) or an
amendment to other material information contained or incorporated by reference in the Initial Registration Statement, any New Registration
Statement, or the Prospectus or any Prospectus Supplement contained in the Initial Registration Statement or any New Registration Statement
(it being hereby acknowledged and agreed that the filing by the Company with the Commission of a quarterly report on Form 10-Q that
includes only updated financial information as of the end of the Company’s most recent fiscal quarter shall not, in and of itself,
constitute an “amendment” or “restatement” for purposes of clause (ii) of this Section 6.15), in each
case of this clause (ii) if the Company is not also then required under the Securities Act to file a post-effective amendment to
the Initial Registration Statement, any New Registration Statement or a post-effective amendment to any New Registration Statement, in
each case with respect to a fiscal year ending after the Commencement Date, to register the resale of Securities by the Investor under
the Securities Act pursuant to this Agreement and the Registration Rights Agreement, and in any case of this clause (ii), not more than
once per calendar quarter, the Company shall (I) deliver to the Investor a Compliance Certificate, dated such date, and (II) cause
to be furnished to the Investor an opinion “bring down” from outside counsel to the Company substantially in the form mutually
agreed to by the Company and the Investor prior to the date of this Agreement, modified, as necessary, to relate to such Registration
Statement or post-effective amendment, or the Prospectus contained therein as then amended or supplemented by such Prospectus Supplement,
as applicable (each such opinion, a “Bring Down Opinion”).


 


Article VII

CONDITIONS TO CLOSING AND CONDITIONS TO THE SALE AND

PURCHASE OF THE SHARES


 


Section 7.1.          Conditions
Precedent to Closing. The Closing is subject to the satisfaction of each of the conditions
set forth in this Section 7.1 on the Closing Date.


 


(i)
           Accuracy of the
Investor’s Representations and Warranties. The representations and warranties of the Investor contained in this Agreement
(a) that are not qualified by “materiality” shall be true and correct in all material respects as of the Closing Date,
except to the extent such representations and warranties are as of another date, in which case, such representations and warranties shall
be true and correct in all material respects as of such other date and (b) that are qualified by “materiality” shall
be true and correct as of the Closing Date, except to the extent such representations and warranties are as of another date, in which
case, such representations and warranties shall be true and correct as of such other date.


 



    	 	27	 



     

    




 


(ii)           Accuracy
of the Company’s and Operating Partnership’s Representations and Warranties. The representations and warranties of
the Company and the Operating Partnership contained in this Agreement (a) that are not qualified by “materiality” or
 “Material Adverse Effect” shall be true and correct in all material respects as of the Closing Date, except to the extent
such representations and warranties are as of another date, in which case, such representations and warranties shall be true and correct
in all material respects as of such other date and (b) that are qualified by “materiality” or “Material Adverse
Effect” shall be true and correct as of the Closing Date, except to the extent such representations and warranties are as of another
date, in which case, such representations and warranties shall be true and correct as of such other date.


 


(iii)          Payment
of Investor Expense Reimbursement. Prior to the Closing Date, the Company shall have paid by wire transfer of immediately available
funds to an account designated by the Investor, the Investor Expense Reimbursement in accordance with Section 10.1(i), all of which
Investor Expense Reimbursement shall be fully earned and non-refundable as of the Closing Date, regardless of whether any VWAP Purchases
are made or settled hereunder or any subsequent termination of this Agreement.


 


(iv)          Closing
Deliverables. At the Closing, counterpart signature pages of this Agreement and the Registration Rights Agreement executed
by each of the parties hereto shall be delivered as provided in Section 2.2. Simultaneously with the execution and delivery of this
Agreement and the Registration Rights Agreement, the Investor’s counsel shall have received the closing certificate from the Company
and the Operating Partnership, dated the Closing Date, in the form of Exhibit B hereto.


 


Section 7.2.           Conditions
Precedent to Commencement. The right of the Company to commence delivering VWAP Purchase
Notices under this Agreement, and the obligation of the Investor to accept VWAP Purchase Notices delivered to the Investor by the Company
under this Agreement, are subject to the initial satisfaction, at the time of Commencement, of each of the conditions set forth in this
Section 7.2.


 


(i)            Accuracy
of the Company’s and the Operating Partnership’s Representations and Warranties. The representations and warranties
of the Company and the Operating Partnership contained in this Agreement (a) that are not qualified by “materiality”
or “Material Adverse Effect” shall have been true and correct in all material respects when made and shall be true and correct
in all material respects as of the Commencement Date with the same force and effect as if made on such date, except to the extent such
representations and warranties are as of another date, in which case, such representations and warranties shall be true and correct in
all material respects as of such other date and (b) that are qualified by “materiality” or “Material Adverse Effect”
shall have been true and correct when made and shall be true and correct as of the Commencement Date with the same force and effect as
if made on such date, except to the extent such representations and warranties are as of another date, in which case, such representations
and warranties shall be true and correct as of such other date.


 






    	 	28	 



     

    

 


(ii)           Performance
of the Company and the Operating Partnership. Each of the Company and the Operating Partnership shall have performed, satisfied
and complied in all material respects with all covenants, agreements and conditions required by this Agreement and the Registration Rights
Agreement to be performed, satisfied or complied with by the Company and the Operating Partnership, respectively, at or prior to the
Commencement. The Company shall deliver to the Investor on the Commencement Date the compliance certificate substantially in the form
attached hereto as Exhibit C (the “Compliance Certificate”).


 


(iii)           Initial
Registration Statement Effective. The Initial Registration Statement covering the resale by the Investor of the Registrable Securities
included therein required to be filed by the Company with the Commission pursuant to Section 2(a) of the Registration Rights
Agreement shall have been declared effective under the Securities Act by the Commission, and the Investor shall be permitted to utilize
the Prospectus therein to resell all of the Shares included in such Prospectus.


 


(iv)          No
Material Notices. None of the following events shall have occurred and be continuing: (a) receipt of any request by the
Commission or any other federal or state governmental authority for any additional information relating to the Initial Registration Statement,
the Prospectus contained therein or any Prospectus Supplement thereto, or for any amendment of or supplement to the Initial Registration
Statement, the Prospectus contained therein or any Prospectus Supplement thereto; (b) the issuance by the Commission or any other
federal or state governmental authority of any stop order suspending the effectiveness of the Initial Registration Statement or prohibiting
or suspending the use of the Prospectus contained therein or any Prospectus Supplement thereto, or of the suspension of qualification
or exemption from qualification of the Securities for offering or sale in any jurisdiction, or the initiation or contemplated initiation
of any proceeding for such purpose; or (c) the occurrence of any event or the existence of any condition or state of facts, which
makes any statement of a material fact made in the Initial Registration Statement, the Prospectus contained therein or any Prospectus
Supplement thereto untrue or which requires the making of any additions to or changes to the statements then made in the Initial Registration
Statement, the Prospectus contained therein or any Prospectus Supplement thereto in order to state a material fact required by the Securities
Act to be stated therein or necessary in order to make the statements then made therein (in the case of the Prospectus or any Prospectus
Supplement, in light of the circumstances under which they were made) not misleading, or which requires an amendment to the Initial Registration
Statement or a supplement to the Prospectus contained therein or any Prospectus Supplement thereto to comply with the Securities Act
or any other law. Neither the Company nor the Operating Partnership shall have any Knowledge of any event that would reasonably be expected
to have the effect of causing the suspension of the effectiveness of the Initial Registration Statement or the prohibition or suspension
of the use of the Prospectus contained therein or any Prospectus Supplement thereto in connection with the resale of the Registrable
Securities by the Investor.


 


(v)           Other
Commission Filings. The Current Report shall have been filed with the Commission as required pursuant to Section 2.3. The
final Prospectus included in the Initial Registration Statement shall have been filed with the Commission prior to Commencement in accordance
with Section 2.3 and the Registration Rights Agreement. All reports, schedules, registrations, forms, statements, information and
other documents required to have been filed by the Company with the Commission pursuant to the reporting requirements of the Exchange
Act, including all material required to have been filed pursuant to Section 13(a) or 15(d) of the Exchange Act, prior
to Commencement shall have been filed with the Commission.


 






    	 	29	 



     

    

 


(vi)
          No Suspension of Trading in
or Notice of Delisting of Common Stock. Trading in the Common Stock shall not have been suspended by the Commission, the Trading
Market or the FINRA (except for any suspension of trading of limited duration agreed to by the Company, which suspension shall be terminated
prior to the Commencement Date), the Company shall not have received any final and non-appealable notice that the listing or quotation
of the Common Stock on the Trading Market shall be terminated on a date certain (unless, prior to such date certain, the Common Stock
is listed or quoted on any other Eligible Market), nor shall there have been imposed any suspension of, or restriction on, accepting
additional deposits of the Common Stock, electronic trading or book-entry services by DTC with respect to the Common Stock that is continuing,
the Company shall not have received any notice from DTC to the effect that a suspension of, or restriction on, accepting additional deposits
of the Common Stock, electronic trading or book-entry services by DTC with respect to the Common Stock is being imposed or is contemplated
(unless, prior to such suspension or restriction, DTC shall have notified the Company in writing that DTC has determined not to impose
any such suspension or restriction).


 


(vii)         Compliance
with Laws. Each of the Company and the Operating Partnership shall have complied in all material respects with all applicable
federal, state and local governmental laws, rules, regulations and ordinances in connection with the execution, delivery and performance
of this Agreement and the other Transaction Documents to which it is a party and the consummation of the transactions contemplated hereby
and thereby, including, without limitation, the Company shall have obtained all permits and qualifications required by any applicable
state securities or “Blue Sky” laws for the offer and sale of the Securities by the Company to the Investor and the subsequent
resale of the Registrable Securities by the Investor (or shall have the availability of exemptions therefrom).


 


(viii)
       No Injunction. No statute, regulation, order,
decree, writ, ruling or injunction shall have been enacted, entered, promulgated, threatened or endorsed by any court or governmental
authority of competent jurisdiction which prohibits the consummation of or which would materially modify or delay any of the transactions
contemplated by the Transaction Documents.


 


(ix)
          No Proceedings or Litigation.
No action, suit or proceeding before any arbitrator or any court or governmental authority shall have been commenced, and no inquiry
or investigation by any governmental authority shall have been commenced, against the Company, the Operating Partnership or any Subsidiary,
or any of the officers, directors or Affiliates of the Company, the Operating Partnership or any Subsidiary, seeking to restrain, prevent
or change the transactions contemplated by the Transaction Documents, or seeking material damages in connection with such transactions.


 






    	 	30	 



     

    

 


(x)            Listing
of Securities. All of the Securities that have been and may be issued pursuant to this Agreement shall have been approved for
listing or quotation on the Trading Market as of the Commencement Date, subject only to notice of issuance.


 


(xi)           No
Material Adverse Effect. No condition, occurrence, state of facts or event constituting a Material Adverse Effect shall have
occurred and be continuing.


 


(xii)          No
Bankruptcy Proceedings. No Person shall have commenced a proceeding against the Company or the Operating Partnership pursuant
to or within the meaning of any Bankruptcy Law. Neither the Company nor the Operating Partnership shall have, pursuant to or within the
meaning of any Bankruptcy Law, (a) commenced a voluntary case, (b) consented to the entry of an order for relief against it
in an involuntary case, (c) consented to the appointment of a Custodian of the Company or the Operating Partnership or for all or
substantially all of the Company’s or the Operating Partnership’s property, or (d) made a general assignment for the
benefit of its creditors. A court of competent jurisdiction shall not have entered an order or decree under any Bankruptcy Law that (I) is
for relief against the Company or the Operating Partnership in an involuntary case, (II) appoints a Custodian of the Company or
of the Operating Partnership or for all or substantially all of the Company’s or the Operating Partnership’s property, or
(III) orders the liquidation of the Company, the Operating Partnership or any of the Subsidiaries.


 


(xiii)         Delivery
of Commencement Irrevocable Transfer Agent Instructions and Notice of Effectiveness. The Commencement Irrevocable Transfer Agent
Instructions shall have been executed by the Company and delivered to acknowledged in writing by the Transfer Agent, and the Notice of
Effectiveness relating to the Initial Registration Statement shall have been executed by the Company’s outside counsel and delivered
to the Transfer Agent, in each case directing the Transfer Agent to issue to the Investor or its designated Broker-Dealer all of the
Shares included in the Initial Registration Statement as DWAC Shares in accordance with this Agreement and the Registration Rights Agreement.


 


(xiv)         Reservation
of Shares. As of the Commencement Date, the Company shall have reserved out of its authorized and unissued Common Stock, 46,227,744
shares of Common Stock solely for the purpose of effecting VWAP Purchases under this Agreement.


 


(xv)         Opinions
of Company Counsel. On the Commencement Date, the Investor shall have received the opinion and negative assurances from outside
counsel to the Company and the Operating Partnership, dated the Commencement Date, in the forms mutually agreed to by the Company and
the Investor prior to the date of this Agreement.


 


Section 7.3.           Conditions
Precedent to VWAP Purchases after Commencement Date. The right of the Company to deliver
VWAP Purchase Notices under this Agreement after the Commencement Date, and the obligation of the Investor to accept VWAP Purchase Notices
under this Agreement after the Commencement Date, are subject to the satisfaction of each of the conditions set forth in this Section 7.3
at the applicable VWAP Purchase Commencement Time for the VWAP Purchase to be effected pursuant to the applicable VWAP Purchase Notice
timely delivered by the Company to the Investor in accordance with this Agreement (each such time, a “VWAP Purchase Condition
Satisfaction Time”).


 






    	 	31	 



     

    

 


(i)            Satisfaction
of Certain Prior Conditions. Each of the conditions set forth in subsections (i), (ii), and (vii) through (xiv) set
forth in Section 7.2 shall be satisfied at the applicable VWAP Purchase Condition Satisfaction Time after the Commencement Date
(with the terms “Commencement” and “Commencement Date” in the conditions set forth in subsections (i) and
(ii) of Section 7.2 replaced with “applicable VWAP Purchase Condition Satisfaction Time”); provided, however, that
the Company shall not be required to deliver the Compliance Certificate after the Commencement Date, except as provided in Section 6.15
and Section 7.3(v).


 


(ii)            Initial
Registration Statement Effective. The Initial Registration Statement covering the resale by the Investor of the Registrable Securities
included therein filed by the Company with the Commission pursuant to Section 2(a) of the Registration Rights Agreement, and
any post-effective amendment thereto required to be filed by the Company with the Commission after the Commencement Date and prior to
the applicable VWAP Purchase Date (as applicable) pursuant to the Registration Rights Agreement, in each case shall have been declared
effective under the Securities Act by the Commission and shall remain effective for the applicable Registration Period (as defined in
the Registration Rights Agreement), and the Investor shall be permitted to utilize the Prospectus therein, and any Prospectus Supplement
thereto, to resell (a) all of the Shares included in the Initial Registration Statement, and any post-effective amendment thereto,
that have been issued and sold to the Investor hereunder pursuant to all VWAP Purchase Notices (as applicable) delivered by the Company
to the Investor prior to such VWAP Purchase Date, and (b) all of the Shares included in the Initial Registration Statement, and
any post-effective amendment thereto, that are issuable pursuant to the applicable VWAP Purchase Notice delivered by the Company to the
Investor with respect to a VWAP Purchase to be effected hereunder on such applicable VWAP Purchase Date.


 


(iii)           Any
Required New Registration Statement Effective. Any New Registration Statement covering the resale by the Investor of the Registrable
Securities included therein, and any post-effective amendment thereto, required to be filed by the Company with the Commission pursuant
to the Registration Rights Agreement after the Commencement Date and prior to the applicable VWAP Purchase Date, in each case shall have
been declared effective under the Securities Act by the Commission and shall remain effective for the applicable Registration Period,
and the Investor shall be permitted to utilize the Prospectus therein, and any Prospectus Supplement thereto, to resell (a) all
of the Shares included in such New Registration Statement, and any post-effective amendment thereto, that have been issued and sold to
the Investor hereunder pursuant to all VWAP Purchase Notices delivered by the Company to the Investor prior to such applicable VWAP Purchase
Date, and (b) all of the Shares included in such new Registration Statement, and any post-effective amendment thereto, that are
issuable pursuant to the applicable VWAP Purchase Notice delivered by the Company to the Investor with respect to a VWAP Purchase to
be effected hereunder on such applicable VWAP Purchase Date.


 


(iv)          Delivery
of Subsequent Irrevocable Transfer Agent Instructions and Notice of Effectiveness. With respect to any post-effective amendment
to the Initial Registration Statement, any New Registration Statement or any post-effective amendment to any New Registration Statement,
in each case declared effective by the Commission after the Commencement Date, the Company shall have delivered or caused to be delivered
to the Transfer Agent (a) irrevocable instructions in the form substantially similar to the Commencement Irrevocable Transfer Agent
Instructions executed by the Company and acknowledged in writing by the Transfer Agent and (b) the Notice of Effectiveness, in each
case modified as necessary to refer to such Registration Statement or post-effective amendment and the Registrable Securities included
therein, to issue the Registrable Securities included therein as DWAC Shares in accordance with the terms of this Agreement and the Registration
Rights Agreement.


 






    	 	32	 



     

    

 


(v)            No
Material Notices. None of the following events shall have occurred and be continuing: (a) receipt of any request by the
Commission or any other federal or state governmental authority for any additional information relating to the Initial Registration Statement
or any post-effective amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained
in any of the foregoing or any Prospectus Supplement thereto, or for any amendment of or supplement to the Initial Registration Statement
or any post-effective amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained
in any of the foregoing or any Prospectus Supplement thereto; (b) the issuance by the Commission or any other federal or state governmental
authority of any stop order suspending the effectiveness of the Initial Registration Statement or any post-effective amendment thereto,
any New Registration Statement or any post-effective amendment thereto, or prohibiting or suspending the use of the Prospectus contained
in any of the foregoing or any Prospectus Supplement thereto, or of the suspension of qualification or exemption from qualification of
the Securities for offering or sale in any jurisdiction, or the initiation or contemplated initiation of any proceeding for such purpose;
or (c) the occurrence of any event or the existence of any condition or state of facts, which makes any statement of a material
fact made in the Initial Registration Statement or any post-effective amendment thereto, any New Registration Statement or any post-effective
amendment thereto, or the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto untrue or which requires
the making of any additions to or changes to the statements then made in the Initial Registration Statement or any post-effective amendment
thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the foregoing
or any Prospectus Supplement thereto in order to state a material fact required by the Securities Act to be stated therein or necessary
in order to make the statements then made therein (in the case of the Prospectus or any Prospectus Supplement, in light of the circumstances
under which they were made) not misleading, or which requires an amendment to the Initial Registration Statement or any post-effective
amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the
foregoing or any Prospectus Supplement thereto to comply with the Securities Act or any other law (other than the transactions contemplated
by the applicable VWAP Purchase Notice delivered by the Company to the Investor with respect to a VWAP Purchase to be effected hereunder
on such applicable VWAP Purchase Date and the settlement thereof). Neither the Company nor the Operating Partnership shall have any Knowledge
of any event that would reasonably be expected to have the effect of causing the suspension of the effectiveness of the Initial Registration
Statement or any post-effective amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the prohibition
or suspension of the use of the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto in connection with
the resale of the Registrable Securities by the Investor.


 






    	 	33	 



     

    

 


(vi)         Other
Commission Filings. The final Prospectus included in any post-effective amendment to the Initial Registration Statement, and
any Prospectus Supplement thereto, required to be filed by the Company with the Commission pursuant to Section 2.3 and the Registration
Rights Agreement after the Commencement Date and prior to the applicable VWAP Purchase Date, shall have been filed with the Commission
in accordance with Section 2.3 and the Registration Rights Agreement. The final Prospectus included in any New Registration Statement
and in any post-effective amendment thereto, and any Prospectus Supplement thereto, required to be filed by the Company with the Commission
pursuant to Section 2.3 and the Registration Rights Agreement after the Commencement Date and prior to the applicable VWAP Purchase
Date, shall have been filed with the Commission in accordance with Section 2.3 and the Registration Rights Agreement. All reports,
schedules, registrations, forms, statements, information and other documents required to have been filed by the Company with the Commission
pursuant to the reporting requirements of the Exchange Act, including all material required to have been filed pursuant to Section 13(a) or
15(d) of the Exchange Act, after the Commencement Date and prior to the applicable VWAP Purchase Date, shall have been filed with
the Commission and, if any Registrable Securities are covered by a Registration Statement on Form S-3, such filings shall have been
made within the applicable time period prescribed for such filing under the Exchange Act.


 


(vii)          No
Suspension of Trading in or Notice of Delisting of Common Stock. Trading in the Common Stock shall not have been suspended by
the Commission, the Trading Market or the FINRA (except for any suspension of trading of limited duration agreed to by the Company, which
suspension shall be terminated prior to the applicable VWAP Purchase Date), the Company shall not have received any final and non-appealable
notice that the listing or quotation of the Common Stock on the Trading Market shall be terminated on a date certain (unless, prior to
such date certain, the Common Stock is listed or quoted on any other Eligible Market), nor shall there have been imposed any suspension
of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC with respect
to the Common Stock that is continuing, the Company shall not have received any notice from DTC to the effect that a suspension of, or
restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC with respect to the
Common Stock is being imposed or is contemplated (unless, prior to such suspension or restriction, DTC shall have notified the Company
in writing that DTC has determined not to impose any such suspension or restriction).


 


(viii)        Certain
Limitations. The issuance and sale of the Shares issuable pursuant to the applicable VWAP Purchase Notice shall not (a) exceed
the applicable VWAP Purchase Maximum Amount, or (b) cause the Aggregate Limit or the Beneficial Ownership Limitation to be exceeded.


 


(ix)           Shares
Authorized and Delivered. All of the Shares issuable pursuant to the applicable VWAP Purchase Notice shall have been duly authorized
by all necessary corporate action of the Company. All Shares relating to all prior VWAP Purchase Notices required to have been received
by the Investor as DWAC Shares under this Agreement prior to the applicable VWAP Purchase Condition Satisfaction Time for the applicable
VWAP Purchase shall have been delivered to the Investor as DWAC Shares in accordance with this Agreement.


 


(x)            Bring-Down
Opinions of Company Counsel. The Investor shall have received (a) all Bring Down Opinions from outside counsel to the Company
and the Operating Partnership for which the Company and the Operating Partnership were obligated to instruct their outside counsel to
deliver to the Investor prior to the applicable VWAP Purchase Condition Satisfaction Time for the applicable VWAP Purchase and (b) all
Compliance Certificates from the Company and the Operating Partnership that the Company and the Operating Partnership were obligated
to deliver to the Investor prior to the applicable prior to the applicable VWAP Purchase Condition Satisfaction Time for the applicable
VWAP Purchase, in each case in accordance with Section 6.15.


 






    	 	34	 



     

    

 


Article VIII

TERMINATION


 


Section 8.1.          Automatic
Termination. Unless earlier terminated as provided hereunder, this Agreement shall terminate
automatically on the earliest to occur of (i) the first day of the month next following the 24-month anniversary of the Commencement
Date, (ii) the earlier of (A) date on which the Investor shall have purchased the Total Purchase Commitment of Shares pursuant
to this Agreement and (B) the Company shall have issued the Aggregate Limit of shares of Common Stock pursuant to this Agreement,
(iii) the date on which the Common Stock shall have failed to be listed or quoted on the Trading Market or any other Eligible Market,
and (iv) the date on which, pursuant to or within the meaning of any Bankruptcy Law, the Company or the Operating Partnership commences
a voluntary case or any Person commences a proceeding against the Company or the Operating Partnership, a Custodian is appointed for
the Company or for the Operating Partnership or for all or substantially all of their respective property, or the Company or the Operating
Partnership makes a general assignment for the benefit of its creditors.


 


Section 8.2.           Other
Termination. Subject to Section 8.3, the Company may terminate this Agreement after
the Commencement Date effective upon ten (10) Trading Days’ prior written notice to the Investor in accordance with Section 10.4;
provided, however, that prior to issuing any press release, or making any public statement or announcement, with respect to such termination,
the Company shall consult with the Investor and its counsel on the form and substance of such press release or other disclosure. Subject
to Section 8.3, this Agreement may be terminated at any time by the mutual written consent of the parties, effective as of the date
of such mutual written consent unless otherwise provided in such written consent. Subject to Section 8.3, the Investor shall have
the right to terminate this Agreement effective upon ten (10) Trading Days’ prior written notice to the Company in accordance
with Section 10.4, if: (a) any condition, occurrence, state of facts or event constituting a Material Adverse Effect has occurred
and is continuing; (b) a Fundamental Transaction shall have occurred; (c) the Initial Registration Statement and any New Registration
Statement is not filed by the applicable Filing Deadline therefor or declared effective by the Commission by the applicable Effectiveness
Deadline (as defined in the Registration Rights Agreement) therefor, or the Company is otherwise in breach or default in any material
respect under any of the other provisions of the Registration Rights Agreement, and, if such failure, breach or default is capable of
being cured, such failure, breach or default is not cured within 10 Trading Days after notice of such failure, breach or default is delivered
to the Company pursuant to Section 10.4; (d) while a Registration Statement, or any post-effective amendment thereto, is required
to be maintained effective pursuant to the terms of the Registration Rights Agreement and the Investor holds any Registrable Securities,
the effectiveness of such Registration Statement, or any post-effective amendment thereto, lapses for any reason (including, without
limitation, the issuance of a stop order by the Commission) or such Registration Statement or any post-effective amendment thereto, the
Prospectus contained therein or any Prospectus Supplement thereto otherwise becomes unavailable to the Investor for the resale of all
of the Registrable Securities included therein in accordance with the terms of the Registration Rights Agreement, and such lapse or unavailability
continues for a period of 20 consecutive Trading Days, other than due to acts of the Investor; (e) trading in the Common Stock on
the Trading Market (or if the Common Stock is then listed on an Eligible Market, trading in the Common Stock on such Eligible Market)
shall have been suspended and such suspension continues for a period of three (3) consecutive Trading Days; or (f) the Company
or the Operating Partnership is in material breach or default of this Agreement, and, if such breach or default is capable of being cured,
such breach or default is not cured within 10 Trading Days after notice of such breach or default is delivered to the Company or the
Operating Partnership (as applicable) pursuant to Section 10.4. Unless notification thereof is required elsewhere in this Agreement
(in which case such notification shall be provided in accordance with such other provision), the Company shall promptly (but in no event
later than 24 hours) notify the Investor (and, if required under applicable law, including, without limitation, Regulation FD promulgated
by the Commission, or under the applicable rules and regulations of the Trading Market (or if the Common Stock is then listed on
an Eligible Market, the rules and regulations of such Eligible Market), the Company shall publicly disclose such information in
accordance with Regulation FD and the applicable rules and regulations of the Trading Market, or the applicable rules and regulations
of such Eligible Market, as applicable) upon becoming aware of any of the events set forth in the immediately preceding sentence.


 






    	 	35	 



     

    

 


Section 8.3.           Effect
of Termination. In the event of termination by the Company or the Investor (other than by
mutual termination) pursuant to Section 8.2, written notice thereof shall forthwith be given to the other party as provided in Section 10.4
and the transactions contemplated by this Agreement shall be terminated without further action by either party. If this Agreement is
terminated as provided in Section 8.1 or Section 8.2, this Agreement shall become void and of no further force and effect,
except that (i) the provisions of Article V (Representations, Warranties and Covenants of the Company and the Operating Partnership),
Article IX (Indemnification), Article X (Miscellaneous) and this Article VIII (Termination) shall remain in full force
and effect indefinitely notwithstanding such termination, and, (ii) so long as the Investor owns any Securities, the covenants and
agreements of the Company and the Operating Partnership contained in Article VI (Additional Covenants) shall remain in full force
and notwithstanding such termination for a period of six (6) months following such termination. Notwithstanding anything in this
Agreement to the contrary, no termination of this Agreement by any party shall (i) become effective prior to the first Trading Day
immediately following the Trading Day on which any then outstanding VWAP Purchase has been fully settled in accordance with Section 3.2
of this Agreement (for the avoidance of doubt, such VWAP Purchase shall be considered “fully settled” when all of the Shares
purchased by the Investor thereunder shall have been received by the Investor as DWAC Shares, and the Investor shall have delivered to
the Company the applicable total VWAP Purchase Price for all such Shares purchased by the Investor thereunder, in each case in accordance
with Section 3.2), (ii) limit, alter, modify, change or otherwise affect the parties’ respective rights or obligations
under the Registration Rights Agreement, all of which shall survive any such termination, or (iii) affect the Investor Expense Reimbursement
paid to the Investor, all of which shall be non-refundable when paid as of the Closing Date pursuant to Section 10.1(i), regardless
of whether any VWAP Purchases are made or settled hereunder or any subsequent termination of this Agreement. Nothing in this Section 8.3
shall be deemed to release the Company, the Operating Partnership or the Investor from any liability for any breach or default under
this Agreement or any of the other Transaction Documents to which it is a party, or to impair the respective rights of the Company, the
Operating Partnership and the Investor to compel specific performance by the other party of its obligations under the Transaction Documents
to which it is a party.


 


Article IX

INDEMNIFICATION


 


Section 9.1.           Indemnification
of Investor. In consideration of the Investor’s execution and delivery of this Agreement
and acquiring the Securities hereunder and in addition to all of the other respective obligations of the Company and the Operating Partnership
under the Transaction Documents to which it is a party, subject to the provisions of this Section 9.1, the Company and the Operating
Partnership, jointly and severally, shall indemnify and hold harmless the Investor, each of its directors, officers, shareholders, members,
partners, employees, representatives, agents and advisors (and any other Persons with a functionally equivalent role of a Person holding
such titles notwithstanding the lack of such title or any other title), each Person, if any, who controls the Investor (within the meaning
of Section 15 of the Securities Act or Section 20(a) of the Exchange Act), and the respective directors, officers, shareholders,
members, partners, employees, representatives, agents and advisors (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding the lack of such title or any other title) of such controlling Persons (each, an “Investor
Party”), from and against all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses (including
all judgments, amounts paid in settlement, court costs, reasonable attorneys’ fees and costs of defense and investigation) (collectively,
 “Damages”) that any Investor Party may suffer or incur as a result of or relating to (a) any breach of
any of the representations, warranties, covenants or agreements made by the Company or the Operating Partnership in this Agreement or
in the other Transaction Documents to which it is a party or (b) any action, suit, claim or proceeding (including for these purposes
a derivative action brought on behalf of the Company) instituted against such Investor Party arising out of or resulting from the execution,
delivery, performance or enforcement of the Transaction Documents, other than claims for indemnification within the scope of Section 6
of the Registration Rights Agreement; provided, however, that (x) the foregoing indemnity shall not apply to any Damages to the
extent, but only to the extent, that such Damages resulted directly and primarily from any acts or failures to act, undertaken or omitted
to be taken by such Investor Party through its fraud, bad faith, gross negligence, or willful or reckless misconduct.


 


The Company and the Operating
Partnership, jointly and severally, shall reimburse any Investor Party promptly upon demand (with accompanying presentation of documentary
evidence) for all legal and other costs and expenses reasonably incurred by such Investor Party in connection with (i) any action,
suit, claim or proceeding, whether at law or in equity, to enforce compliance by the Company or the Operating Partnership with any provision
of the Transaction Documents to which it is a party or (ii) any other any action, suit, claim or proceeding, whether at law or in
equity, with respect to which it is entitled to indemnification under this Section 9.1; provided that the Investor shall promptly
reimburse the Company or the Operating Partnership, as applicable, for all such legal and other costs and expenses to the extent a court
of competent jurisdiction determines that any Investor Party was not entitled to such reimbursement.


 



    	 	36	 



     

    





 


An Investor Party’s
right to indemnification or other remedies based upon the representations, warranties, covenants and agreements of the Company and the
Operating Partnership set forth in the Transaction Documents to which it is a party shall not in any way be affected by any investigation
or knowledge of such Investor Party. Such representations, warranties, covenants and agreements shall not be affected or deemed waived
by reason of the fact that an Investor Party knew or should have known that any representation or warranty might be inaccurate or that
the Company or the Operating Partnership, as applicable, failed to comply with any agreement or covenant. Any investigation by such Investor
Party shall be for its own protection only and shall not affect or impair any right or remedy hereunder.


 


To the extent that the foregoing
joint and several undertakings by the Company and the Operating Partnership set forth in this Section 9.1 may be unenforceable for
any reason, the Company and the Operating Partnership, jointly and severally, shall make the maximum contribution to the payment and
satisfaction of each of the Damages which is permissible under applicable law.


 


Section 9.2.           Indemnification
Procedures. Promptly after an Investor Party receives notice of a claim or the commencement of
an action for which the Investor Party intends to seek indemnification under Section 9.1, the Investor Party will notify the Company
or the Operating Party in writing of the claim or commencement of the action, suit or proceeding; provided, however, that
failure to notify the Company and the Operating Party will not relieve the Company and the Operating Party from liability under Section 9.1,
except to the extent it has been materially prejudiced by the failure to give notice. Each of the Company and the Operating Partnership
will be entitled to participate in the defense of any claim, action, suit or proceeding as to which indemnification is being sought,
and if each of the Company and the Operating Partnership acknowledges in writing the joint and severable obligation to indemnify the
Investor Party against whom the claim or action is brought, either the Company or the Operating Partnership, or both, may (but will not
be required to) assume the defense against the claim, action, suit or proceeding with counsel satisfactory to it. After the Company or
the Operating Partnership notifies the Investor Party that the Company and/or the Operating Party wishes to assume the defense of a claim,
action, suit or proceeding, neither the Company nor the Operating Party will be liable for any further legal or other expenses incurred
by the Investor Party in connection with the defense against the claim, action, suit or proceeding except that if, in the opinion of
counsel to the Investor Party, it would be inappropriate under the applicable rules of professional responsibility for the same
counsel to represent both the Company and/or the Operating Partnership and such Investor Party. In such event, the Company and the Operating
Partnership, jointly and severally, will pay the reasonable fees and expenses of no more than one separate counsel for all such Investor
Parties promptly as such fees and expenses are incurred. Each Investor Party, as a condition to receiving indemnification as provided
in Section 9.1, will cooperate in all reasonable respects with the Company and the Operating Partnership, as applicable, in the
defense of any action or claim as to which indemnification is sought. Neither the Company nor the Operating Partnership will be liable
for any settlement of any action effected without its prior written consent, which consent shall not be unreasonably withheld, delayed
or conditioned. Neither the Company nor the Operating Party will, without the prior written consent of the Investor Party, effect any
settlement of a pending or threatened action with respect to which an Investor Party is, or is informed that it may be, made a party
and for which it would be entitled to indemnification, unless the settlement includes an unconditional release of the Investor Party
from all liability and claims which are the subject matter of the pending or threatened action.


 






    	 	37	 



     

    

 


The remedies provided for
in this Article IX are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Investor
Party at law or in equity.


 


Article X

MISCELLANEOUS


 


Section 10.1.         Certain
Fees and Expenses Each party shall bear its own fees and expenses related to the transactions contemplated
by this Agreement; provided, however, that the Company shall have paid, prior to the date of this Agreement, by wire transfer of immediately
available funds to an account designated by the Investor, an amount equal to $50,000 to be applied against the Investor’s reasonable
out-of-pocket expenses, including the legal fees and disbursements of the Investor’s legal counsel, incurred by the Investor in
connection with the preparation, negotiation, execution and delivery of the Transaction Documents by the Investor and its due diligence
investigation of the Company and the Operating Partnership (such amount, the “Investor Expense Reimbursement”). For the avoidance
of doubt, the Investor Expense Reimbursement shall be non-refundable when paid as of the Closing Date, regardless of whether any VWAP
Purchases are made or settled hereunder or any subsequent termination of this Agreement. The Company shall pay all U.S. federal, state
and local stamp and other similar transfer and other taxes and duties levied in connection with issuance of the Securities pursuant hereto.


 


Section 10.2.         Specific
Enforcement, Consent to Jurisdiction, Waiver of Jury Trial.


 


(i)             The
Company, the Operating Partnership and the Investor acknowledge and agree that irreparable damage would occur in the event that any of
the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly
agreed that the Company and the Operating Partnership, on the one hand, and the Investor, on the other hand, shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of this Agreement by the other party and to enforce specifically
the terms and provisions hereof (without the necessity of showing economic loss and without any bond or other security being required),
this being in addition to any other remedy to which either party may be entitled by law or equity.


 


(ii)            Each
of the Company, the Operating Partnership and the Investor (a) hereby irrevocably submits to the jurisdiction of the U.S. District
Court and other courts of the United States sitting in the State of New York for the purposes of any suit, action or proceeding arising
out of or relating to this Agreement, and (b) hereby waives, and agrees not to assert in any such suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient
forum or that the venue of the suit, action or proceeding is improper. Each of the Company, the Operating Partnership and the Investor
consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing in this Section 10.2 shall affect or limit any right to serve process in any other manner permitted by law.


 






    	 	38	 



     

    

 


(iii)           EACH
OF THE COMPANY, THE OPERATING PARTNERSHIP AND THE INVESTOR HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT
IT MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR DISPUTES RELATING HERETO. EACH OF THE COMPANY, THE OPERATING PARTNERSHIP AND THE
INVESTOR (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT
SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND
THE OTHER PARTIES HERETO HAVE BEEN TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS
SECTION 10.2.


 


Section 10.3.         Entire
Agreement. The Transaction Documents set forth the entire agreement and understanding of the parties
with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, negotiations and understandings between
the parties, both oral and written, with respect to such matters. There are no promises, undertakings, representations or warranties
by either party relative to subject matter hereof not expressly set forth in the Transaction Documents. The Disclosure Schedule and all
exhibits to this Agreement are hereby incorporated by reference in, and made a part of, this Agreement as if set forth in full herein.


 


Section 10.4.         Notices.
Any notice, demand, request, waiver or other communication required or permitted to be given hereunder shall be in writing and shall
be effective (a) upon hand delivery or electronic mail delivery at the address or number designated below (if delivered on a business
day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered
other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day
following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing,
whichever shall first occur. The address for such communications shall be:


 


If to the Company or the
Operating Partnership:


 


Ashford Hospitality Trust, Inc.


14185 Dallas Parkway Suite 1200


Dallas,
TX 75254

Telephone Number: (972) 778-9451


Email: deubanks@ashfordinc.com


Attention: Deric S. Eubanks


 


With a copy (which shall
not constitute notice) to:


 


Cadwalader, Wickersham & Taft LLP


200 Liberty Street


New
York, NY 10291

Telephone Number: (212) 504-6780


Facsimile: (212) 494-6596


Email: greg.patti@cwt.com

Attention: Gregory P. Patti, Jr., Esq.


 






    	 	39	 



     

    

 


If to the Investor:


 


B. Riley Principal Capital, LLC


11100 Santa Monica Blvd., Suite 800


Los Angeles, CA 90025

Telephone Number: (310) 966-1444


Email: legal@brileyfin.com


Attention: General Counsel


 


With a copy (which shall
not constitute notice) to:


 


Dorsey &
Whitney LLP


51 West 52nd
Street


New York, NY 10019


Telephone Number:
(212) 415-9214


Facsimile: (212)
953-7201


Email: marsico.anthony@dorsey.com


Attention: Anthony J. Marsico, Esq.


 


Either party hereto may from time to time change
its address for notices by giving at least five (5) days’ advance written notice of such changed address to the other party
hereto.


 


Section 10.5.         Waivers.
No provision of this Agreement may be waived by the parties from and after the date that is one (1) Trading Day immediately preceding
the filing of the Initial Registration Statement with the Commission. Subject to the immediately preceding sentence, no provision of
this Agreement may be waived other than in a written instrument signed by the party against whom enforcement of such waiver is sought.
No failure or delay in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single
or partial exercise of any such power, right or privilege preclude other or further exercises thereof or of any other right, power or
privilege.


 


Section 10.6.         Amendments.
No provision of this Agreement may be amended by the parties from and after the date that is one (1) Trading Day immediately preceding
the filing of the Initial Registration Statement with the Commission. Subject to the immediately preceding sentence, no provision of
this Agreement may be amended other than by a written instrument signed by both parties hereto.


 


Section 10.7.         Headings.
The article, section and subsection headings in this Agreement are for convenience only and shall not constitute a part of this Agreement
for any other purpose and shall not be deemed to limit or affect any of the provisions hereof. Unless the context clearly indicates otherwise,
each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms “including,”
 “includes,” “include” and words of like import shall be construed broadly as if followed by the words “without
limitation.” The terms “herein,” “hereunder,” “hereof” and words of like import refer to this
entire Agreement instead of just the provision in which they are found.


 






    	 	40	 



     

    

 


Section 10.8.         Construction.
The parties agree that each of them and their respective counsel has reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of the Transaction Documents. In addition, each and every reference to share prices (including
the Threshold Price) and number of shares of Common Stock in any Transaction Document shall, in all cases, be subject to adjustment for
any stock splits, stock combinations, stock dividends, recapitalizations, reorganizations and other similar transactions that occur on
or after the date of this Agreement. Any reference in this Agreement to “Dollars” or “$” shall mean the lawful
currency of the United States of America. Any references to “Section” or “Article” in this Agreement shall, unless
otherwise expressly stated herein, refer to the applicable Section or Article of this Agreement.


 


Section 10.9.         Binding
Effect. This Agreement shall be binding upon and inure to the benefit of the parties hereto and
their respective successors. None of the Company, the Operating Partnership or the Investor may assign this Agreement or any of their
respective rights or obligations hereunder to any Person.


 


Section 10.10.       No
Third Party Beneficiaries. Except as expressly provided in Article IX, this Agreement is intended
only for the benefit of the parties hereto and their respective successors, and is not for the benefit of, nor may any provision hereof
be enforced by, any other Person.


 


Section 10.11.       Governing
Law. This Agreement shall be governed by and construed in accordance with the internal procedural
and substantive laws of the State of New York, without giving effect to the choice of law provisions of such state that would cause the
application of the laws of any other jurisdiction.


 


Section 10.12.       Survival.
The representations, warranties, covenants and agreements of the Company, the Operating Partnership and the Investor contained in this
Agreement shall survive the execution and delivery hereof until the termination of this Agreement; provided, however, that
(i) the provisions of Article V (Representations, Warranties and Covenants of the Company and the Operating Partnership), Article VIII
(Termination), Article IX (Indemnification) and this Article X (Miscellaneous) shall remain in full force and effect indefinitely
notwithstanding such termination, and, (ii) so long as the Investor owns any Securities, the covenants and agreements of the Company,
the Operating Partnership and the Investor contained in Article VI (Additional Covenants), shall remain in full force and effect
notwithstanding such termination for a period of six (6) months following such termination.


 


Section 10.13.       Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile
signature or signature delivered by e-mail in a “.pdf” format data file, including any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and
shall be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.


 






    	 	41	 



     

    

 


Section 10.14.       Publicity.
The Company shall afford the Investor and its counsel with a reasonable opportunity to review and comment upon, shall consult with the
Investor and its counsel on the form and substance of, and shall give due consideration to all such comments from the Investor or its
counsel on, any press release, Commission filing or any other public disclosure made by or on behalf of the Company relating to the Investor,
its purchases hereunder or any aspect of the Transaction Documents or the transactions contemplated thereby, prior to the issuance, filing
or public disclosure thereof. For the avoidance of doubt, the Company shall not be required to submit for review any such disclosure
(i) contained in periodic reports filed with the Commission under the Exchange Act if it shall have previously provided the same
disclosure to the Investor or its counsel for review in connection with a previous filing or (ii) any Prospectus Supplement if it
contains disclosure that does not reference the Investor, its purchases hereunder or any aspect of the Transaction Documents or the transactions
contemplated thereby.


 


Section 10.15.       Severability.
The provisions of this Agreement are severable and, in the event that any court of competent jurisdiction shall determine that any one
or more of the provisions or part of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal
or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision
of this Agreement, and this Agreement shall be reformed and construed as if such invalid or illegal or unenforceable provision, or part
of such provision, had never been contained herein, so that such provisions would be valid, legal and enforceable to the maximum extent
possible.


 


Section 10.16.       Further
Assurances. From and after the Closing Date, upon the request of the Investor, the Operating Partnership
or the Company, each of the Company, the Operating Partnership and the Investor shall execute and deliver such instrument, documents
and other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes
of this Agreement.


 


[Signature Pages Follow]


 



    	 	42	 



     

    




 


IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officer
as of the date first above written.


 


	 	THE COMPANY:
	 	 
	 	ASHFORD HOSPITALITY TRUST, INC.:
	 	 
	 	By :	/s/ J. Robison Hays, III                    
	 	Name: J. Robison Hays, III
	 	Title: President and Chief Executive Officer
	 	 
	 	THE OPERATING PARTNERSHIP:
	 	 
	 	ASHFORD HOSPITALITY LIMITED PARTNERSHIP
	 	 
	 	By: Ashford OP General Partner LLC, its sole general partner
	 	 
	 	By: Ashford Hospitality Trust, Inc., its sole member
	 	 
	 	By:	/s/ Deric S. Eubanks
	 	Name: Deric S. Eubanks
	 	Title: Chief Financial Officer and Treasurer
	 	 
	 	THE INVESTOR:
	 	 
	 	B. RILEY PRINCIPAL CAPITAL, LLC:
	 	 
	 	By:	/s/ Dan Shribman
	 	Name: Dan Shribman
	 	Title: Chief Investment Officer


 



    


     


    




 



 


ANNEX
I TO THE

COMMON STOCK PURCHASE AGREEMENT

DEFINITIONS


 


“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control
with a Person, as such terms are used in and construed under Rule 144. With respect to the Investor, without limitation, any Person
owning, owned by, or under common ownership with the Investor, and any investment fund or managed account that is managed on a discretionary
basis by the same investment manager as the Investor will be deemed to be an Affiliate.


 


“Aggregate Limit”
shall have the meaning assigned to such term in Section 3.3(a).


 


“Agreement”
shall have the meaning assigned to such term in the preamble of this Agreement.


 


“Bankruptcy Law”
means Title 11, U.S. Code, or any similar U.S. federal or state law for the relief of debtors.


 


“Beneficial Ownership
Limitation” shall have the meaning assigned to such term in Section 3.4.


 


“Bloomberg”
means Bloomberg, L.P.


 


“Bring Down Opinion”
shall have the meaning assigned to such term in Section 6.15.


 


“Broker-Dealer”
shall have the meaning assigned to such term in Section 6.13.


 


“Bylaws”
shall have the meaning assigned to such term in Section 5.3.


 


“CERCLA”
shall have the meaning assigned to such term in Section 5.18.


 


“Charter”
shall have the meaning assigned to such term in Section 5.3.


 


“Common Stock”
shall have the meaning assigned to such term in the recitals of this Agreement.


 


“Common Stock
Equivalents” means any securities of the Company, the Operating Partnership or the Subsidiaries which would entitle the
holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or
other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to
receive, Common Stock.


 


“Closing”
shall have the meaning assigned to such term in Section 2.2.


 


“Closing Date”
means the date of this Agreement.


 






    I-1


     


    

 


“Closing Sale
Price” means, for the Common Stock as of any date, the last closing trade price for the Common Stock on the Trading Market
(or, if the Common Stock is then listed on an Eligible Market, on such Eligible Market), as reported by Bloomberg, or, if the Trading
Market (or such Eligible Market, as applicable) begins to operate on an extended hours basis and does not designate the closing trade
price for the Common Stock, then the last trade price for the Common Stock prior to 4:00 p.m., New York City time, as reported by Bloomberg.
All such determinations shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or
other similar transactions during such period.


 


“Code”
means the Internal Revenue Code of 1986, as amended.


 


“Commencement”
shall have the meaning assigned to such term in Section 3.1.


 


“Commencement
Date” shall have the meaning assigned to such term in Section 3.1.


 


“Commencement
Irrevocable Transfer Agent Instructions” shall have the meaning assigned to such term in Section 10.1(iv).


 


“Commission”
means the U.S. Securities and Exchange Commission or any successor entity.


 


“Commission Documents”
shall mean (1) all reports, schedules, registrations, forms, statements, information and other documents filed with or furnished
to the Commission by the Company pursuant to the reporting requirements of the Exchange Act, including all material filed with or furnished
to the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act, since December 31, 2020, including,
without limitation, the Annual Report on Form 10-K filed by the Company for its fiscal year ended December 31, 2020 (the “2020
Form 10-K”), and which hereafter shall be filed with or furnished to the Commission by the Company, including, without
limitation, the Current Report, (2) each Registration Statement, as the same may be amended from time to time, the Prospectus contained
therein and each Prospectus Supplement thereto and (3) all information contained in such filings and all documents and disclosures
that have been and heretofore shall be incorporated by reference therein.


 


“Common Stock”
shall have the meaning assigned to such term in the recitals of this Agreement.


 


“Common Stock
Equivalents” means any securities of the Company, the Operating Partnership or the Subsidiaries which would entitle the
holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or
other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to
receive, Common Stock.


 


“Common Units”
shall have the meaning assigned to such term in Section 5.8.


 


“Company”
shall have the meaning assigned to such term in the preamble of this Agreement.


 


“Compliance Certificate”
shall have the meaning assigned to such term in Section 7.2(ii).


 


“Current Report”
shall have the meaning assigned to such term in Section 2.3.


 






    I-2


     


    

 


“Cover Price”
shall have the meaning assigned to such term in Section 3.2.


 


“Custodian”
shall mean any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.


 


“Damages”
shall have the meaning assigned to such term in Section 9.1.


 


“Dilutive Issuance”
shall have the meaning assigned to such term in Section 6.6(ii).


 


“Disclosure Schedule”
shall have the meaning assigned to such term in the preamble to Article V.


 


“Disqualification
Event” shall have the meaning assigned to such term in Section 5.39.


 


“DTC”
means The Depository Trust Company, a subsidiary of The Depository Trust & Clearing Corporation, or any successor thereto.


 


“DWAC”
shall have the meaning assigned to such term in Section 5.33.


 


“DWAC
Shares” means shares of Common Stock issued pursuant to this Agreement that are (i) issued in electronic form, (ii) freely
tradable and transferable and without restriction on resale and without stop transfer instructions maintained against the transfer thereof
and (iii) timely credited by the Company to the Investor’s or its designated Broker-Dealer at which the account or accounts
to be credited with the Securities being purchased by Investor are maintained specified DWAC account with DTC under its Fast Automated
Securities Transfer (FAST) Program, or any similar program hereafter adopted by DTC performing substantially the same function.


 


“EDGAR”
means the Commission’s Electronic Data Gathering, Analysis and Retrieval System.


 


“Effective Date”
means, with respect to the Initial Registration Statement filed pursuant to Section 2(a) of the Registration Rights Agreement
(or any post-effective amendment thereto) or any New Registration Statement filed pursuant to Section 2(c) of the Registration
Rights Agreement (or any post-effective amendment thereto), as applicable, the date on which the Initial Registration Statement (or any
post-effective amendment thereto) or any New Registration Statement (or any post-effective amendment thereto) is declared effective by
the Commission.


 


“Effectiveness
Deadline” shall have the meaning assigned to such term in the Registration Rights Agreement.


 


“Eligible Market”
means The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market or the NYSE American (or any nationally recognized
successor to any of the foregoing).


 


“Environmental
Laws” shall have the meaning assigned to such term in Section 5.18 hereof.


 






    I-3


     


    

 


“Exchange Act”
means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder.


 


“Exempt
Issuance” means the issuance of (a) Common Stock, options or other equity incentive awards to employees, officers,
directors or vendors of the Company pursuant to any equity incentive plan duly adopted for such purpose, by the Company’s Board
of Directors or a majority of the members of a committee of the Board of Directors established for such purpose, (b) (1) any
Securities issued to the Investor pursuant to this Agreement, (2) any securities issued upon the exercise or exchange of or conversion
of any shares of Common Stock or Common Stock Equivalents held by the Investor or an Affiliate of the Investor at any time, or (3) any
securities issued upon the exercise or exchange of or conversion of any Common Stock Equivalents issued and outstanding on the date of
this Agreement, provided that such securities referred to in this clause (3) have not been amended since the date of this Agreement
to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities, (c) securities
issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided
that such securities are issued as “restricted securities” (as defined in Rule 144) and carry no registration rights
that require or permit the filing of any registration statement in connection therewith, and, provided that any such issuance shall only
be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of
an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to
the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising
capital or to an entity whose primary business is investing in securities, or (d) any securities issued by the Company at any time
from and after the date of this Agreement in exchange for any shares of its 8.45% Series D Cumulative Preferred Stock, par
value $0.01 per share, shares of its 7.375% Series F Cumulative Preferred Stock, par value $0.01 per share, shares of its 7.375%
Series G Cumulative Preferred Stock, par value $0.01 per share, shares of its 7.50% Series H Cumulative Preferred Stock, par
value $0.01 per share, and/or shares of 7.50% Series I Cumulative Preferred Stock, par value $0.01 per share, issued and outstanding
as of the date of this Agreement, pursuant to one or more privately negotiated exchange agreements with existing holders of such securities,
in reliance on the exemption from the registration requirements of the Securities Act contained in Section 3(a)(9) of the Securities
Act on the basis that such transactions constitute an exchange of securities by the Company with existing holders of the Company’s
securities exclusively where no commission or other remuneration is paid or given directly or indirectly to any party for soliciting such
exchange.


 


“FCPA”
shall have the meaning assigned to such term in Section 5.35.


 


“Filed Commission
Document” shall have the meaning assigned to such term in Section 5.6.


 


“Filing Deadline”
shall have the meaning assigned to such term in the Registration Rights Agreement.


 


“FINRA”
means the Financial Industry Regulatory Authority.


 






    I-4


     


    

 


“Fundamental
Transaction” means that (i) the Company shall, directly or indirectly, in one or more related transactions,
(1) consolidate or merge with or into (whether or not the Company is the surviving corporation) another Person, with the result that
the holders of the Company’s capital stock immediately prior to such consolidation or merger together beneficially own less than
50% of the outstanding voting power of the surviving or resulting corporation, or (2) sell, lease, license, assign, transfer, convey
or otherwise dispose of all or substantially all of the properties or assets of the Company to another Person, or (3) take action
to facilitate a purchase, tender or exchange offer by another Person that is accepted by the holders of the Company’s Voting Stock
representing more than 50% of the total voting power of the Company’s Voting Stock (excluding any Voting Stock held by the Person
or Persons making or party to, or associated or affiliated with the Persons making or party to, such purchase, tender or exchange offer),
or (4) consummate a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires Voting Stock of the Company
representing more than 50% of the total voting power of the Company’s Voting Stock (not including any Voting Stock held by the other
Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination), or (5) reorganize, recapitalize or reclassify its Common Stock, or (ii) any
 “person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange
Act) is or shall become the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly,
of Voting Stock of the Company representing more than 50% of the total voting power of the Company’s Voting Stock.


 


“GAAP”
shall have the meaning assigned to such term in Section 5.6(b).


 


“General Partner”
shall have the meaning assigned to such term in Section 5.8.


 


“Governmental
Authority” shall have the meaning assigned to such term in Section 5.18.


 


“Hazardous Material”
shall have the meaning assigned to such term in Section 5.18.


 


“Initial Registration
Statement” shall have the meaning assigned to such term in the Registration Rights Agreement.


 


“Investment Period”
means the period commencing on the Effective Date of the Initial Registration Statement and expiring on the date this Agreement is terminated
pursuant to Article VIII.


 


“Investor”
shall have the meaning assigned to such term in the preamble of this Agreement.


 


“Investor Expense
Reimbursement” shall have the meaning assigned to such term in Section 10.1(i).


 


“Investor Party”
shall have the meaning assigned to such term in Section 9.1.


 


“Issuer Covered
Person” shall have the meaning assigned to such term in Section 5.39.


 


“IT Systems”
shall have the meaning assigned to such term in Section 5.38.


 






    I-5


     


    

 


“Knowledge”
means, with respect to the Company and the Operating Partnership, the actual knowledge of the Company’s Chief Executive Officer
and President, its Chief Financial Officer and Treasurer, and its General Counsel, in each case after reasonable inquiry of all officers,
directors and employees of the Company and its Subsidiaries under their direct supervision who would reasonably be expected to have knowledge
or information with respect to the matter in question.


 


“Limited Partner”
shall have the meaning assigned to such term in Section 5.8.


 


“Material Adverse
Effect” means any material adverse effect on (i) the enforceability of any Transaction Document, (ii) the results
of operations, assets, business or financial condition of the Company, the Operating Partnership and its Subsidiaries, taken as a whole,
other than any material adverse effect that resulted primarily from (A) any change in the United States or foreign economies or securities
or financial markets in general, (B) any change that generally affects the industry in which the Company, the Operating Partnership
and its Subsidiaries operate, (C) any change arising in connection with earthquakes, hostilities, acts of war, sabotage or terrorism
or military actions or any escalation or material worsening of any such hostilities, acts of war, sabotage or terrorism or military actions
existing as of the date hereof, (D) any action taken by the Investor, its affiliates or its or their successors and assigns with
respect to the transactions contemplated by this Agreement and the Registration Rights Agreement, (E) the effect of any change in
applicable laws or accounting rules, or (F) any change resulting from compliance with terms of this Agreement or the Registration
Rights Agreement or the consummation of the transactions contemplated by this Agreement and the Registration Rights Agreement, or (iii) the
Company’s or the Operating Partnership’s ability to perform in any material respect on a timely basis its obligations under
any Transaction Document to which it is a party to be performed as of the date of determination.


 


“Material Agreements”
shall have the meaning assigned to such term in Section 5.19.


 


“Money Laundering
Laws” shall have the meaning assigned to such term in Section 5.36.


 


“New Registration
Statement” shall have the meaning assigned to such term in the Registration Rights Agreement.


 


“Notice of Effectiveness”
shall have the meaning assigned to such term in Section 10.1(iv).


 


“OFAC”
shall have the meaning assigned to such term in Section 5.37.


 


“Operating Partnership”
shall have the meaning assigned to such term in the preamble.


 


“Partnership Agreement”
shall have the meaning assigned to such term in Section 5.3.


 


“PEA Period”
means the period commencing at 9:30 a.m., New York City time, on the fifth (5th) Trading Day immediately prior to the filing
of any post-effective amendment to the Initial Registration Statement or any New Registration Statement, and ending at 9:30 a.m., New
York City time, on the Trading Day immediately following, the Effective Date of such post-effective amendment.


 






    I-6


     


    

 


“Person”
means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership, limited liability company,
trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.


 


“Personal Data”
shall have the meaning assigned to such term in Section 5.38.


 


“Preferred Units”
shall have the meaning assigned to such term in Section 5.8.


 


“Prospectus”
means the prospectus in the form included in a Registration Statement, as supplemented from time to time by any Prospectus Supplement,
including the documents incorporated by reference therein.


 


“Prospectus Supplement”
means any prospectus supplement to the Prospectus filed with the Commission from time to time pursuant to Rule 424(b) under
the Securities Act, including the documents incorporated by reference therein.


 


“Real Property”
shall have the meaning assigned to such term in Section 5.18.


 


“Registrable Securities”
shall have the meaning assigned to such term in the Registration Rights Agreement.


 


“Registration
Rights Agreement” shall have the meaning assigned to such term in the recitals hereof.


 


“Registration
Statement” shall have the meaning assigned to such term in the Registration Rights Agreement.


 


“Regulation D”
shall mean Regulation D promulgated by the Commission under the Securities Act.


 


“REIT”
shall have the meaning assigned to such term in Section 5.40.


 


“Restricted Period”
shall have the meaning assigned to such term in Section 6.9(i).


 


“Restricted Person”
shall have the meaning assigned to such term in Section 6.9(i).


 


“Restricted Persons”
shall have the meaning assigned to such term in Section 6.9(i).


 


“Rule 144”
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect.


 


“Sanctions”
shall have the meaning assigned to such term in Section 5.37.


 


“Sanctioned Countries”
shall have the meaning assigned to such term in Section 5.37.


 


“Sanctioned Country”
shall have the meaning assigned to such term in Section 5.37.


 


“Sanctioned Persons”
shall have the meaning assigned to such term in Section 5.37.


 






    I-7


     


    

 


“Section 4(a)(2)”
shall have the meaning assigned to such term in the recitals of this Agreement.


 


“Securities”
means the Shares.


 


“Securities Act”
shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder.


 


“Shares”
shall mean the shares of Common Stock that are and/or may be purchased by the Investor under this Agreement pursuant to one or more VWAP
Purchase Notices.


 


“Short Sales”
shall mean “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act.


 


“Stock Plan”
shall have the meaning assigned to such term in Section 5.24.


 


“Subsidiary”
and “Subsidiaries” shall have the meanings assigned to such terms in Section 5.1.


 


“Total Purchase
Commitment” shall have the meaning assigned to such term in Section 2.1.


 


“Threshold Price”
means, with respect to a VWAP Purchase, $1.00, which shall be appropriately adjusted for any reorganization, recapitalization, non-cash
dividend, stock split or other similar transaction and, effective upon the consummation of any such reorganization, recapitalization,
non-cash dividend, stock split or other similar transaction, the “Threshold Price” shall mean the lower of (i) the adjusted
price and (ii) $1.00.


 


“Trading Day”
shall mean any day on which the Trading Market or, if the Common Stock is then listed on an Eligible Market, such Eligible Market is open
for trading (regular way), including any day on which the Trading Market (or such Eligible Market, as applicable) is open for trading
(regular way) for a period of time less than the customary time.


 


“Trading Market”
means the New York Stock Exchange (or any nationally recognized successor thereto).


 


“Transaction Documents”
means, collectively, this Agreement (as qualified by the Disclosure Schedule) and the exhibits hereto, the Registration Rights Agreement
and each of the other agreements, documents, certificates and instruments entered into or furnished by the parties hereto in connection
with the transactions contemplated hereby and thereby.


 


“Transfer Agent”
means Computershare Trust Company, or such other Person who is then serving as the transfer agent for the Company in respect of the Common
Stock.


 






    I-8


     


    

 


“Variable Rate
Transaction” means a transaction in which the Company (i) issues or sells any equity or debt securities that are convertible
into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock or Common Stock Equivalents either
(A) at a conversion price, exercise price, exchange rate or other price that is based upon and/or varies with the trading prices
of or quotations for the Common Stock at any time after the initial issuance of such equity or debt securities, or (B) with a conversion,
exercise or exchange price that is subject to being reset at some future date after the initial issuance of such equity or debt security
or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for
the Common Stock (including, without limitation, any “full ratchet” or “weighted average” anti-dilution provisions,
but not including any standard anti-dilution protection for any reorganization, recapitalization, non-cash dividend, stock split or other
similar transaction), (ii) issues or sells any equity or debt securities, including without limitation, Common Stock or Common Stock
Equivalents, either (A) at a price that is subject to being reset at some future date after the initial issuance of such debt or
equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company
or the market for the Common Stock (other than standard anti-dilution protection for any reorganization, recapitalization, non-cash dividend,
stock split or other similar transaction), or (B) that are subject to or contain any put, call, redemption, buy-back, price-reset
or other similar provision or mechanism (including, without limitation, a “Black-Scholes” put or call right, other than in
connection with a “fundamental transaction”) that provides for the issuance of additional equity securities of the Company
or the payment of cash by the Company, or (iii) enters into any agreement with any Person other than the Investor or an Affiliate
of the Investor, including, but not limited to, an “equity line of credit” or “at the market offering” or other
continuous offering or similar offering of Common Stock or Common Stock Equivalents, whereby the Company may sell Common Stock or Common
Stock Equivalents at a future determined price.


 


“Voting Stock”
means securities of any class or kind having the power to vote generally for the election of directors, managers or other voting members
of the governing body of the Company or any successor thereto.


 


“VWAP”
means, for the Common Stock for a specified period, the dollar volume-weighted average price for the Common Stock on the Trading Market
(or, if the Common Stock is then listed on an Eligible Market, on such Eligible Market), for such period, as reported by Bloomberg through
its “AQR” function. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination,
recapitalization or other similar transaction during such period.


 


“VWAP Purchase”
shall have the meaning assigned to such term in Section 3.1.


 


“VWAP Purchase
Condition Satisfaction Time” shall have the meaning assigned to such term in Section 7.3.


 


“VWAP Purchase
Confirmation” shall have the meaning assigned to such term in Section 3.1.


 


“VWAP Purchase
Commencement Time” means, with respect to a VWAP Purchase made pursuant to Section 3.1, 9:30:01 a.m., New York City
time, on the applicable VWAP Purchase Date, or such later time on such VWAP Purchase Date publicly announced by the Trading Market (or,
if the Common Stock is then listed on an Eligible Market, by such Eligible Market) as the official open (or commencement) of trading (regular
way) on the Trading Market (or such Eligible Market, as applicable) on such VWAP Purchase Date.


 






    I-9


     


    

 


“VWAP Purchase
Date” means, with respect to a VWAP Purchase made pursuant to Section 3.1, the Trading Day on which the Investor receives,
after 6:00 a.m., New York City time, but prior to 9:00 a.m., New York City time, on such Trading Day, a valid VWAP Purchase Notice for
such VWAP Purchase in accordance with this Agreement.


 


“VWAP Purchase
Maximum Amount” means, with respect to a VWAP Purchase made pursuant to Section 3.1, a number of shares of Common Stock
equal to the lesser of (i) a number of shares of Common Stock which, when aggregated with all other shares of Common Stock then
beneficially owned by the Investor and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3
promulgated thereunder), would result in the beneficial ownership by the Investor of more than the Beneficial Ownership
Limitation and (ii) a number of Shares equal to (A) the VWAP Purchase Share Percentage multiplied by (B) the total number
(or volume) of shares of Common Stock traded on the Trading Market (or, if the Common Stock is then listed on an Eligible Market, on such
Eligible Market) during the applicable VWAP Purchase Period on the applicable VWAP Purchase Date for such VWAP Purchase.


 


“VWAP Purchase
Notice” means, with respect to a VWAP Purchase made pursuant to Section 3.1, an irrevocable written notice delivered
by the Company to the Investor directing the Investor to purchase a VWAP Purchase Share Amount (such specified VWAP Purchase Share Amount
subject to adjustment as set forth in Section 3.1 as necessary to give effect to the VWAP Purchase Maximum Amount), at the applicable
VWAP Purchase Price therefor on the applicable VWAP Purchase Date for such VWAP Purchase in accordance with this Agreement.


 


“VWAP Purchase
Period” means, with respect to a VWAP Purchase made pursuant to Section 3.1, the period on the applicable VWAP Purchase
Date for such VWAP Purchase beginning at the applicable VWAP Purchase Commencement Time and ending at the applicable VWAP Purchase Termination
Time.


 


“VWAP Purchase
Price” means, with respect to a VWAP Purchase made pursuant to Section 3.1, the purchase price per Share to be purchased
by the Investor in such VWAP Purchase equal to ninety-six and a half percent (96.5%) of the VWAP over the applicable VWAP Purchase Period
on the applicable VWAP Purchase Date for such VWAP Purchase (to be appropriately adjusted for any reorganization, recapitalization, non-cash
dividend, stock split, reverse stock split or other similar transaction).


 


“VWAP Purchase
Share Amount” means, with respect to a VWAP Purchase made pursuant to Section 3.1, the number of Shares to be purchased
by the Investor in such VWAP Purchase as specified by the Company in the applicable VWAP Purchase Notice, which number of Shares shall
not exceed the applicable VWAP Purchase Maximum Amount.


 


“VWAP Purchase
Share Delivery Date” shall have the meaning assigned to such term in Section 3.2.


 


“VWAP Purchase
Share Percentage” means, with respect to a VWAP Purchase made pursuant to Section 3.1, thirty percent (30%).


 






    I-10


     


    

 


“VWAP Purchase
Termination Time” means, with respect to a VWAP Purchase made pursuant to Section 3.1, 4:00 p.m., New York City time,
on the applicable VWAP Purchase Date, or such earlier time publicly announced by the Trading Market (or, if the Common Stock is then listed
on an Eligible Market, by such Eligible Market) as the official close of trading (regular way) on the Trading Market on such applicable
VWAP Purchase Date.


 






    I-11


     


    

 


EXHIBIT A
TO THE

COMMON STOCK PURCHASE AGREEMENT


 


[TO BE FURNISHED SEPARATELY]


 






    A-1


     


    

 


EXHIBIT B
TO THE

COMMON STOCK PURCHASE AGREEMENT

CERTiFICATE OF THE COMPANY


 


CLOSING
CERTIFICATE


 


[●],
2021


 


The undersigned, the [●]
of Ashford Hospitality Trust, Inc., a Maryland corporation (the “Company”), delivers this certificate in
connection with the Common Stock Purchase Agreement, dated as of July [●], 2021 (the “Agreement”),
by and between the Company, Ashford Hospitality Limited Partnership, a Delaware limited partnership (the “Operating Partnership”),
and B. Riley Principal Capital, LLC, a Delaware limited liability company (the “Investor”), and hereby certifies
on the date hereof that (capitalized terms used herein without definition have the meanings assigned to them in the Agreement):


 


1.             Attached
hereto as Exhibit A is a true, complete and correct copy of the Certificate of Incorporation of the Company, as amended through
the date hereof, as filed with the Secretary of State of the State of Maryland. The Certificate of Incorporation of the Company has not
been further amended or restated, and no document with respect to any amendment to the Certificate of Incorporation of the Company has
been filed in the office of the Secretary of State of the State of Maryland since the date shown on the face of the state certification
relating to the Company’s Certificate of Incorporation, which is in full force and effect on the date hereof, and no action has
been taken by the Company in contemplation of any such amendment or the dissolution, merger or consolidation of the Company.


 


2.             Attached
hereto as Exhibit B is a true and complete copy of the Bylaws of the Company, as amended and restated through, and as in
full force and effect on, the date hereof, and no proposal for any amendment, repeal or other modification to the Bylaws of the Company
has been taken or is currently pending before the Board of Directors or stockholders of the Company.


 


3.             The
Board of Directors of the Company has approved the transactions contemplated by the Transaction Documents; said approval has not been
amended, rescinded or modified and remains in full force and effect as of the date hereof. Attached hereto as Exhibit C are
true, correct and complete copies of the resolutions duly adopted by the Board of Directors of the Company via unanimous written consent
on [●], 2021.


 


4.             Each
person who, as an officer of the Company, or as attorney-in-fact of an officer of the Company, signed the Transaction Documents to which
the Company is a party, was duly elected, qualified and acting as such officer or duly appointed and acting as such attorney-in-fact,
and the signature of each such person appearing on any such document is his genuine signature.


 


IN
WITNESS WHEREOF, I have signed my name as of the date first above written.


 


	 	 
	 	Name:
	 	Title:


 



    B-1


     


    




 


EXHIBIT C
TO THE

COMMON STOCK PURCHASE AGREEMENT

COMPLIANCE CERTIFICATE


 


The undersigned, the [●]
of Ashford Hospitality Trust, Inc., a Maryland corporation (the “Company”), delivers this certificate in
connection with the Common Stock Purchase Agreement, dated as of July [●], 2021 (the “Agreement”),
by and between the Company, Ashford Hospitality Limited Partnership, a Delaware limited partnership (the “Operating Partnership”),
and B. Riley Principal Capital, LLC, a Delaware limited liability company (the “Investor”), and hereby certifies
on the date hereof that, to the best of his knowledge after reasonable investigation, on behalf of the Company and the Operating Partnership
(capitalized terms used herein without definition have the meanings assigned to them in the Agreement):


 


1.             The
undersigned is the duly appointed [●] of the Company.


 


2.             Except
as set forth in the attached Disclosure Schedule, the representations and warranties of the Company and the Operating Partnership set
forth in Article V of the Agreement (i) that are not qualified by “materiality” or “Material Adverse Effect”
are true and correct in all material respects as of [the Commencement Date] [the date hereof] with the same force and effect as if made
on [the Commencement Date] [the date hereof], except to the extent such representations and warranties are as of another date, in which
case, such representations and warranties are true and correct in all material respects as of such other date and (ii) that are qualified
by “materiality” or “Material Adverse Effect” are true and correct as of [the Commencement Date] [the date hereof]
with the same force and effect as if made on [the Commencement Date] [the date hereof], except to the extent such representations and
warranties are as of another date, in which case, such representations and warranties are true and correct as of such other date.


 


3.             Each
of the Company and the Operating Partnership has performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Agreement and the Registration Rights Agreement to be performed, satisfied or complied with by the Company
and the Operating Partnership, respectively, [at or prior to Commencement][on or prior to the date hereof].


 


4.             The
Shares issuable in respect of each VWAP Purchase Notice effected pursuant to the Agreement shall be delivered to the Investor electronically
as DWAC Shares, and shall be freely tradable and transferable and without restriction on resale and without any stop transfer instructions
maintained against such Shares.


 


5.             As
of [the Commencement Date][the date hereof], neither the Company nor the Operating Partnership possesses any material non-public information.


 


6.             As
of [the Commencement Date][the date hereof], the Company has reserved out of its authorized and unissued Common Stock, [●] shares
of Common Stock solely for the purpose of effecting VWAP Purchases under the Agreement.


 


7.             No
stop order suspending the effectiveness of the Registration Statement or the use of the Prospectus under the Securities Act has been issued
and no proceedings for such purpose or pursuant to Section 8A of the Securities Act are pending before or, to the Knowledge of the
Company and the Operating Partnership, threatened by the Commission.


 


The undersigned has executed
this Certificate this [●] day of [●], 20[●].


 






    C-1


     


    

 


	 	By:	 
	 	Name:	 
	 	Title:	 


 






    C-2


     


    

 




DISCLOSURE SCHEDULE

RELATING TO THE COMMON STOCK

PURCHASE AGREEMENT, DATED AS OF JULY [●], 2021

BY AND AMONG ASHFORD HOSPITALITY TRUST, INC., ASHFORD HOSPITALITY LIMITED PARTNERSHIP AND B. Riley Principal Capital, LLC


 


This disclosure schedule is
made and given pursuant to Article V of the Common Stock Purchase Agreement, dated as of July [●], 2021 (the “Agreement”),
by and between Ashford Hospitality Trust, Inc., a Maryland corporation (the “Company”), Ashford Hospitality
Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), and B. Riley Principal Capital,
LLC, a Delaware limited liability company (the “Investor”). Unless the context otherwise requires, all capitalized
terms are used herein as defined in the Agreement. The numbers below correspond to the section numbers of representations and warranties
in the Agreement most directly modified by the below exceptions.